HEROES Teaming Profiles
Thank you for your interest in ARPA-H’s HEalth care Rewards to Achieve Improved OutcomES (HEROES) program. This page is designed to help facilitate connections between prospective performer teams. If either you or your organization are interested in teaming, please submit your information via the form below. Your details will then be added to the list below, which is publicly available.
HEROES anticipates that teaming will be necessary to achieve the goals of the program. Prospective performers are encouraged (but not required) to form teams with varied technical expertise to submit a proposal to the HEROES. For questions, please contact us via the HEROES portal. If interested in teaming and need help with reaching potential partners, please register to join upcoming office hours.
Please note that by publishing the teaming profiles list, ARPA-H is not endorsing, sponsoring, or otherwise evaluating the qualifications of the individuals or organizations included here. Submissions to the teaming profiles list are reviewed and updated periodically.
Interested in learning more about the HEROES program?
Teaming Profiles List
To narrow the results in the Teaming Profiles List, please use the input below to filter results based on your search term. The list will filter as you type.
| Organization name | Point of contact name | Point of contact email | Provide an additional point of contact for your organization's representative (email only) | Location | In 200 words or less, describe your organization's current research focus areas | In 200 words or less, tell us what your organization is looking for in potential teaming partners | The HEROES program has identified four outcomes that have continued health burden despite the availability of effective, evidence-based interventions to mitigate health risks at the population lev... |
| 4th Sector | Dev Nathan Kalyan | Dev@4th-sector.com | Paul@4th-sector.com | WASHINGTON DC, DALLAS TX | 4th Sector is leading the implementation science and strategic planning and infrastructure development to enable continuous patient-centered outcomes improvement for the nation's largest integrated health systems. | A combination of proven solutions to make a meaningful impact on the measure outcomes in the time horizon of the HEROES program | Heart attack and stroke risk;Opioid overdoses;Serious obstetric complications (maternal health);Alcohol-related health harms; |
| Naveon | Matthew Rachleff | matthew@naveonguides.com | Baton Rouge, LA | Serious illness and metabolic health. | Not sure yet | Serious obstetric complications (maternal health);Heart attack and stroke risk;Opioid overdoses;Alcohol-related health harms; | |
| Pediatric Moonshot/BevelCloud Inc. | Julee Sung | julee@bevelcloud.io | tim@bevelcloud.io | Marina del Rey, CA | Pediatric Moonshot aims to reduce healthcare inequity, lower costs, and improve outcomes for children everywhere, especially in rural communities, with real-time, privacy-preserving AI applications. | We partner with organizations inside and outside healthcare interested in leveraging our technology platform that enables real-time, privacy-preserving image sharing as well as our AI research lab for children's medicine. | Serious obstetric complications (maternal health);Alcohol-related health harms;Heart attack and stroke risk;Opioid overdoses; |
| Pennington Biomedical Research Center | Kenneth Eilertsen | Kenneth.Eilertsen@pbrc.edu | Guy.LaVergne@pbrc.edu | Baton Rouge, Lousiana | Obesity, diabetes and related chronic diseases including cancer. | To be determined | Serious obstetric complications (maternal health);Heart attack and stroke risk;Opioid overdoses;Alcohol-related health harms; |
| Healthy Birth Day, Inc. - Count the Kicks | Megan Aucutt | aucutt.megan@healthybirthday.org | price.emily@healthybirthday.org | Des Moines, IA | Healthy Birth Day, Inc. is currently dedicated to advancing maternal and fetal health through its research focus areas, particularly emphasizing the Count the Kicks program. Our organization is committed to reducing preventable stillbirths and promoting healthy pregnancies nationally. Count the Kicks focuses on empowering expectant parents with a simple yet effective tool: tracking their baby's movements. By raising awareness about the importance of fetal movement monitoring in the third trimester, we aim to equip expectant parents with the knowledge to recognize any potential signs of distress and seek timely medical attention, ultimately reducing the risk of stillbirths and maternal death. Our research endeavors encompass exploring the efficacy of various outreach strategies, digital tools, and educational resources to maximize the impact of the Count the Kicks program. Through collaboration with healthcare professionals, advocacy groups, and communities, we strive to implement evidence-based interventions that support maternal and fetal well-being. By prioritizing research in this vital area, we aspire to make significant strides in promoting healthy pregnancies and ensuring every baby has the best possible start in life. | Healthy Birth Day, Inc. seeks teaming partners who share our commitment to improving maternal and fetal health outcomes across the United States. We prioritize collaboration with organizations and individuals who bring diverse expertise, innovative approaches, and a shared passion for our mission. Specifically, we look for partners who deeply understand the unique challenges surrounding stillbirth prevention and maternal health promotion. Whether it's healthcare professionals, researchers, advocacy groups, or technology innovators, we value partners who can contribute complementary skills and resources to amplify the impact of our initiatives, such as the Count the Kicks campaign. Additionally, we seek partners who are dedicated to evidence-based practices as we prioritize research and data-driven interventions in our work. Furthermore, we value partners committed to inclusivity, equity, and cultural sensitivity, recognizing the importance of addressing disparities in maternal and fetal health outcomes. By fostering collaborative relationships with like-minded organizations, we aim to leverage collective strengths and resources to make a tangible difference in the lives of expectant mothers and their babies. | Serious obstetric complications (maternal health);Heart attack and stroke risk;Alcohol-related health harms;Opioid overdoses; |
| Onai Inc. | Galana Gebisa | info@onai.com | San Jose, CA | We have led projects related to privacy-preserving analysis of EHR and other health data across disparate systems. We also have expertise in verifiable tamperproof privacy-preserving self-measurement/testing and reporting of clinical factors and behaviors, such as for blood pressure, exercise, opioids... Lastly, we can assist with incentive design, investor sourcing, and direct payment operationalization. | We seek reputable organizations with roots in a community and ongoing interactions with populations to be served. We can contribute in the following areas: (1) responsibility for data processing layer; (2) low-cost solutions for health monitoring; and/or (3) investors, incentive design, and direct payment operations. | Heart attack and stroke risk;Alcohol-related health harms;Opioid overdoses;Serious obstetric complications (maternal health); | |
| Right Care Initiative Heart Attack & Stroke Reduction, UC Berkeley School of Public Health | Hattie Rees Hanley, MPP | hattiehanley@post.harvard.edu | Sarah.Epstein@berkeley.edu | Berkeley, CA | Our 16+ year CA collaborative works on reducing morbidity & mortality from heart attacks & strokes with leading cardiologists, neurologists, medical directors, community organizations, public health agencies, including CDC, patients and Universities. Our NIH funded pilot is associated with a 22% decline in AMI's across San Diego County; savings of $86 million and 3,826 fewer acute myocardial infarction hospitalizations than anticipated based on secular trend (published in Health Affairs and AJMC). How? Pressing all health systems in region to bring 75% of their patients at goal for LDL 100, BP 140/90 and A1c 8 or less. We use publicly available county level health system performance data on these measures to bring the systems to the table. We provided them with inspiring patient stories, rich collaborative best practices sharing by top performers and tools. We've seen similar improvement in Sacramento according to CDC data. Now on zoom, regional boundaries have faded away. Through a zoom and Telehealth approach,we believe we can scale this up nationally with the right partners. | We believe that by adding the CAC scan to our successful LDL, HTN, A1C formula, we can drop AMI by at least an additional 10% (1/3 in 5 years). I've used my training at the Harvard Kennedy School of Government to bring data to bear for the greater good. In addition, using my family story of the tragic loss of my mother to stroke when I was just 15 has significantly impacted awareness among health systems across CA on the need to focus on women. She was a brilliant linguist and code breaker. Now I use my inherited translation skills building bridges between communities to drive down MI & Stroke disability and death. When you look at how fast we drove down women's MI in SD, it was because I was co-leading monthly meetings among the medical directors in open square format, feeding them salmon & salad, bringing them outstanding speakers and keeping the conversation passionate about the impact on families when an active parent is ripped away from preventable death, driving all this with our gold bar chart performance data, and bringing my state of CA regulatory colleagues along. | Heart attack and stroke risk;Serious obstetric complications (maternal health);Alcohol-related health harms;Opioid overdoses; |
| Domelabs AI | Austin Crumpton | austin@domelabs.ai | dennis@domelabs.ai | Edina, MN | We have expertise designing, developing, and managing artificial intelligence based solutions that combine behavioral science with improving patient care, outcomes, and costs. This has included both federally funded and corporate based programs that use probabilistic programming approaches to identify high risk prodrome indicators in otherwise healthy populations, the development of tailored adherence treatment protocols, and the integration of extended reality to support telehealth and remote monitoring systems. We are deeply connected to the healthcare systems throughout the United States and would seek to leverage those connections to support the implementation and testing of our solutions. Our team consists of Harvard and MIT graduates who have come together to accelerate the ethical adoption of AI within healthcare. | We would like to collaborate with an organization passionate about developing solutions for that will result in real-world impact. We are specifically looking for teams with expertise in computer science engineering, with tested experience designing and implementing software components in React Native, Java, Python, or C#, and with experience in back-end framework and microservices-based development and publishing reusable components. | Opioid overdoses;Serious obstetric complications (maternal health);Alcohol-related health harms;Heart attack and stroke risk; |
| Medicines360 | Autumn Ehnow | aehnow@medicines360.org | jneal@medicines360.org | San Francisco, CA | Medicines360 is a mission driven organization founded in 2009 to apply a different approach to bringing innovative pharmaceutical drugs and devices to women. We were founded to expand women’s access to an innovative, highly effective contraception option — the hormonal IUD — with a goal of increasing affordability and demonstrating that these devices are safe and effective for more women than had been previously recognized. • Today, we have changed the dynamics of access to the IUD for women in the US. LILETTA, our contraceptive drug-device combination product, received FDA approval in 2015 and has helped close to 1.5 million women to date, including over 500,000 women seen at public health clinics and hospitals. Medicines360 is directing the focus and tenacity we have proven in the contraception space to address a broader range of unmet needs in women’s health, with a focus on maternal health. mothers who deliver preterm babies face increased odds of maternal transfusion, uterine rupture, unplanned hysterectomy, and maternal admission to the ICU. Medicines360 is committed to applying our community approach to this problem in order to ensure that more mothers are able to deliver full-term babies. We are developing an expanded portfolio of maternal health innovations including products designed to prevent preterm births. | If Maternal Health is one of the selected programs; we envision two major components of this program would be needed. The first is the intervention to reach women early in pregnancy to both bring them into the healthcare system as well as maintain contact. This could include needing enrollment into Medicaid. The maintaining contact will need to be able to determine if a complication is developing and provide the guidance to have that women be seen by a healthcare provider. Then there will be the intervention to prevent or stop the complication through all follow-up. These components will need to be part of this program, but also translated into a sustainable intervention. For this, we will leverage our existing as well as new key providers in the community, including departments of health, FQHCs, Universities and others. The outcome buyers will be mostly payers, some programs such as a government program. We will conduct traditional payer research to confirm payer coverage likelihood and would solicit feedback form payers in this program on likelihood of coverage. We also welcome non-dilutive investment and grants to advance this program. | Serious obstetric complications (maternal health);Heart attack and stroke risk;Opioid overdoses;Alcohol-related health harms; |
| OutcomesX | Jason Saul | Jsaul@missionmeasurement.com | Phyllis@outcomesx.com | Chicago, Illinois | We are a market maker, so we focus on building platforms that verify outcome claims and connect buyers with sellers. | We are looking to team with large institutional outcome buyers, venture investors, and financial services firms to create the financial and markets infrastructure to sustain HEROES and ultimately bring this initiative to scale. | Heart attack and stroke risk;Alcohol-related health harms;Opioid overdoses;Serious obstetric complications (maternal health); |
| Cogitativo, Inc. | John Gouzoules | john.gouzoules@cogitativo.com | olivia.frances@cogitativo.com | Berkeley, CA | Cogitativo is a Berkeley based precision health data science company formed through the combination of nationally recognized physician leaders, peer reviewed clinical researchers, seasoned healthcare delivery operators and experienced data scientists. Our pursuit is to offer the utmost transparency into each patient’s unique circumstances, aiming for the highest level of precision in our approach to provide the most actionable insights to enable the best care and outcomes possible for each patient. Our platform, Visión, is a machine learning and data analytics platform that aggregates data from various disparate available sources, such as electronic health records (EHR), claims data, Social Determinants of Health, and clinical literature, to create a comprehensive view of each patient within a patient population. Using our machine learning models, the Vision platform generates a Disease Progression Index (DPI) score for each patient, which identifies their risk of disease progression and measure of a patient's health status, reflecting the quality of care, healthcare equity, and other factors that influence an individual's access to affordable and accessible healthcare. DPI facilitates the continuous monitoring of a patient's health status and provides actionable insights, including modifiable risk factors, to enable early intervention to slow or reverse the progression of chronic diseases. | We're seeking potential partners who share our commitment to enhancing the well-being of vulnerable populations in underserved areas. This includes buyers, such as payors and governmental entities at various levels, such as counties and cities, who are invested in identifying and uplifting those in need. Our primary focus is on pinpointing individuals at risk of chronic disease progression and furnishing evidence-based insights to facilitate early and targeted interventions, ultimately leading to better patient outcomes and significant reductions in long-term healthcare expenses. Additionally, we're interested in collaborating with health systems that currently serve these underserved communities to ensure our insights translate into actionable and timely improvements in the delivery of patient care. | Heart attack and stroke risk;Opioid overdoses;Alcohol-related health harms;Serious obstetric complications (maternal health); |
| MN EHR Consortium | Paul Drawz | draw0003@umn.edu | Minneapolis, MN | The MN EHR Consortium (https://mnehrconsortium.org/) is a partnership between Minnesota health systems and public health agencies to provide timely and granular data to inform the real-time actions of policymakers, health system leaders, and researchers. We focus on informing health policy and practice through comprehensive data and collaboration. Current and recent projects have included a focus on substance use disorders, telehealth, community health assessments for hypertension and diabetes, and COVID syndromic surveillance and vaccine monitoring. | The MN EHR Consortium is interested in teaming with payors and organizations interested in improving quality of care and reducing inequities in care. | Heart attack and stroke risk;Opioid overdoses;Alcohol-related health harms;Serious obstetric complications (maternal health); | |
| Mae Health, Inc. | Maya Hardigan | maya@meetmae.com | alisha@meetmae.com | Brooklyn, NY | Mae is a tech-enabled services solution built to address clinical, structural, social, and cultural needs of underserved expectant mothers, with a focus on Medicaid beneficiaries and race-based disparities. Mae combines digital risk assessment with culturally responsive community-based doula support and group-based education. Mae’s technology identifies physical, emotional, and behavioral needs to provide real-time clinical guidance, and works across doula partners and health plan care coordination teams to ensure robust support for risk factors. Since our launch, we have consistently delivered >30% reductions in C-section rates and >30% reductions in preterm birth rates for our Medicaid plan partners. We have also gathered robust feedback pertaining to the experiences and needs of our users. HEROES offers a path for engaging a broader base of partners in the delivery of Mae’s program: FQHCs, Hospitals, and community-based doula organizations. Because we are contracted with several Medicaid plans, we have a pathway for billing doula support, the most critical aspect of our intervention, fee-for-service through our plan partners. We aspire to develop new features to enhance community care conversion and utilization for increased and widespread care participation, and to deliver a base of evidence for combining digital and community-based services to impact population health outcomes. | With the goal of having Managed Care organizations fund the doula component of our intervention, Mae would welcome MCO participation as Outcomes Buyers in our application. Depending on our geography of focus, we will bring significant partnership into the program (for example, in the state of Michigan, we are already contracted with MCOs representing 50% of the Medicaid market, and we would welcome the opportunity to contract with MCOs with whom we are not yet working, such that we have a reimbursement pathway for as many mothers as we’re able to reach). We would also like to consider partnership with local FQHCs or hospitals servicing high numbers of births (we have found this to be a meaningful enrollment tactic that allows us to both find moms and enroll them at the initial point of care). Because our program is established - notwithstanding our work to continuously strengthen and amplify our model - we are confident we can hit the ground running on the HEROES launch date. However, these partnerships will allow us to turbocharge enrollment, reach moms earlier in their pregnancy journeys, and offer us a reimbursement pathway to ensure that we are delivering our intervention cost effectively. | Serious obstetric complications (maternal health);Alcohol-related health harms;Heart attack and stroke risk;Opioid overdoses; |
| BellSant | Matt Fellowes | livebetter@bellsant.com | emily@bellsant.com | Washington, DC | BellSant is a social mission health-tech company that provides a better approach to annual physicals designed to help people live healthier, happier lives for longer. To do that, we work with a team of leading academics as well as physicians that integrate our technology into their practice. Utilizing our mobile app, higher risk patients are prioritized for physician visits and the brief, once a year wellness screen is transformed into an ongoing experience that improves and sustains health. Each patient receives a comprehensive analysis of health that fuses lab diagnostic data, mental and physical strength assessments, and wearable device data. Members also receive estimates of their biological age, aging trend on 11 major health systems, and custom protocols designed to boost their health and happiness for as long as possible, including guidance related to nutrition, fitness, sleep, meditation, among other protocols related to their daily life. By utilizing more data, implementing more of the USPSTF guidelines, and assessing health more frequently compared to today’s approach to annual physicals, our 2023 trial found that 20% of “healthy” participants had undetected health risks, while 55% of the suboptimal health markers improved after three months. In 2024, our research will assess more population segments and behavior change approaches. | Our team has created and led numerous large, social mission technology firms, includes physicians at Johns Hopkins and Brigham and Women’s Hospital, and is guided by some of the most respected academics in fields related to our mission, including at Johns Hopkins University, University of Chicago, University of Southern California, Harvard University, Columbia University, the University of Pennsylvania, University of Pittsburgh, Stanford University, and many others. In 2024, we are expanding our partnerships by including health systems and payers that share our conviction that utilizing our technology in the annual physical experience can lead to better outcomes for patients, providers, and payers. Participating health systems will have an opportunity to co-develop and customize our technology, as well as an opportunity to utilize the BellSant technology with their patient population. Research oriented institutions will also have an opportunity to participate in original research. Our team is united in our mission to use new, rigorous science and technology to increase the health potential of our members in ways that have not been possible in the past and reverse the decades-long increase in chronic disease rates. | Heart attack and stroke risk;Alcohol-related health harms;Opioid overdoses;Serious obstetric complications (maternal health); |
| Accelerator for Care Transformation | Alexander Blood | ABlood@bwh.harvard.edu | cmailly@mgb.org | Boston, MA | We deliver remote, team-based, scalable care delivery for cardiometabolic disease. Our team has cared for more than 15,000 patients across New England in hypertension, hyperlipidemia, and heart failure. We built an enterprise-grade, bespoke patient-relationship management software to enable device integration, medication management, and care coordination. | We are looking to team with outcome buyers and investors or other care delivery and solution adoption partners in other geographical areas. | Heart attack and stroke risk;Serious obstetric complications (maternal health);Opioid overdoses;Alcohol-related health harms; |
| Independence Blue Cross | Jovi Hammer | Lejan.Hammer@ibx.com | Matthew.Donovan@ibx.com | Philadelphia, Pennsylvania | Our vision is to lead nationally in innovating whole-person health as a diversified health care organization. Our mission is to enhance the health and well-being of the people and communities we serve. Our values are focused on health equity, empowerment, and innovation to bring greater access to high quality care. Our current initiatives are focused on medical education, maternal health, digital health, and equity-focused interventions. | As a health accelerator, we are looking to partner with organizations who can add value and deliver on certain gaps within our existing programs that focus on maternal health, stroke risk, and/or opioid use disorder. Since our IBX Foundation and our Health Equity Institute have developed some programs to address disparities in our region, we are interested in finding partners to fill the missing pieces that could transform our current work into a comprehensive program to qualify as an ARPA-H proposal. As an outcome buyer, we are simply interested in partnering with other payers who share the same goals and priorities in addressing health outcomes. Since the benefits of improving health outcomes is at the population-level and goes beyond the members we serve in our specific health plans, we believe other payers (health plans + employers) should join us as a mutual responsibility for the communities we serve. | Serious obstetric complications (maternal health);Opioid overdoses;Heart attack and stroke risk;Alcohol-related health harms; |
| Pathways Community HUB Institute | Jan Ruma | Janr@pchi-hub.org | Sarahr@pchi-hub.org | Toledo, Ohio | National organization advancing health equity through the Pathways Community HUB Institute Model of CHW driven, outcome focused, carecoordination networks. | Connecting Pathways Community HUBs with HERO community teams to measurably improve health for those most at risk for poor health outcomes. | Serious obstetric complications (maternal health);Heart attack and stroke risk;Opioid overdoses;Alcohol-related health harms; |
| Mobile Health Map at Harvard Medical School | Mollie Williams | mollie_williams@hms.harvard.edu | mobilehealthmap@hms.harvard.edu | Boston, MA | Mobile Health Map, a program of Harvard Medical School, is the largest network of mobile clinics in the U.S. We work with mobile health providers to measure and communicate their impact, with a focus on real-time data, geospatial analysis, and community engagement. Mobile Health Map partners with researchers, hospitals, community health centers, public health departments, primary care associations and other stakeholders to maximize the impact of mobile healthcare efforts. We also operate a mobile clinic in Boston, The Family Van, that has served as a national model for community-engaged healthcare since 1992. | Mobile Health Map seeks partners aligned with our mission to enhance health equity through innovative, community-driven healthcare. Ideal collaborators will share our commitment to improving preventive health care access, particularly for underserved communities. If you are interested in exploring how mobile healthcare can be part of the solution in your geographic areas, we'd love to chat. | Heart attack and stroke risk;Opioid overdoses;Serious obstetric complications (maternal health);Alcohol-related health harms; |
| Advanta Health Solutions, Inc. | Steve Clarke | sclarke@advantahealth.com | chiggins@advantahealth.com | Newark, NJ. | Advanta Health incentivizes physical and mental well-being through incremental behavior change(s). As a central hub to collect and aggregate data, we can compare against claims data to reduce further risk and communicate direct with the end user and provider, seemlessly. | Advanta is looking for a partner that can readily scale upon winning this award. | Heart attack and stroke risk;Opioid overdoses;Serious obstetric complications (maternal health);Alcohol-related health harms; |
| Datavant | Ed Pompili | ed@datavant.com | nickmessina@datavant.com | Phoenix, AZ | Datavant’s mission is to connect the world’s health data to improve patient outcomes. Datavant is the leader in privacy preserving data exchange, working with over 500 institutions to connect health data. Datavant is uniquely positioned to support our clients through the following: -Largest de-identified real-world data ecosystem (RWD), -Privacy-preserving record linkage (PPRL) technology that unlocks major barriers to a scalable real world data strategy, -Privacy-first real world data platform that facilitates discovery and formation of real-world datasets for populations of interest, -Real-world data compliance program that ensures datasets are linked and assembled in accordance with the Expert Determination requirements of the HIPAA Privacy Rule based on client fit-for-purpose data needs, -Largest medical record retrieval network of healthcare providers. Datavant has enabled hundreds of real-world data studies including clinical trials, and our technology is actively used by leading life science, medical device, and diagnostic companies to help them answer important scientific questions. | SMES/data science, data aggregation platforms, data analytics. | Serious obstetric complications (maternal health);Heart attack and stroke risk;Opioid overdoses;Alcohol-related health harms; |
| MPR Associates, Inc. | Ryan Downs, Vice President, Health & Life Science | rdowns@mpr.com | cloper@mpr.com | Virginia | MPR is an engineering consulting firm that focuses on developing technology and planning large scale programs that solve healthcare challenges. MPR works best when partnered with a team that understands the core challenge but lacks the capabilities or bandwidth to design, develop, implement and test the proposed solution to that challenge. MPR designs: • Medical devices, • Pharmaceutical processes, • Hardware solutions, • Software platforms, • Machine learning systems, • User studies, and • Manages large scale government programs. MPR actively supports innovative hospital networks, large medical device and pharmaceutical developers, startups, rural co-operatives, as well as DOD, DOE, and DHS in designing and implementing impactful solutions. MPR understands how to design and develop solutions that deliver results and align with government funding expectations. MPR seeks to partner with those that know what they need to accomplish, and may not have the capabilities or clarity of the process to implement and achieve those lofty goals. | MPR actively supports: • Innovative hospital networks, • Large medical device developers • Pharmaceutical developers, • Startups, • Rural co-operatives, as well as • DOD, DOE, and DHS, in designing and implementing impactful solutions. MPR understands how to design and develop solutions that deliver results and align with government funding expectations. MPR seeks to partner with those that know what they need to accomplish, and may not have the capabilities, bandwidth, or clarity of the process to implement and achieve those lofty goals. | Opioid overdoses;Heart attack and stroke risk;Serious obstetric complications (maternal health);Alcohol-related health harms; |
| Avant Pharmacy & Wellness | Marianna Wilbur | marianna@avantpharmacy.com | amina@avantpharmacy.com | Charlotte NC | Getting community pharmacists to do "anything beyond dispensing" AND get adequately reimbursed for doing so | Outcome buyers | Heart attack and stroke risk;Opioid overdoses;Alcohol-related health harms;Serious obstetric complications (maternal health); |
| DHR Health Institute for Research and Development | Lisa R Trevino, PhD | lis.trevino@dhr-rgv.com | m.betancourt@dhr-rgv.com | Edinburg, Texas | The current clinical research portfolio at the DHR Health Institute for Research and Development aligns with the clinical centers of excellence of our parent Health System, DHR Health. We provide comprehensive, advanced clinical care in the form of clinical trials in the areas of oncology, liver disease, metabolic disorders, neuroscience (Stroke, MS, MG), cardiovascular disease and others. Likewise, we have one of the largest collections of biospecimens for future biobank collaborations. Our patient population is greater than 90% Hispanic and as such a large part of our efforts focuses on education and outreach, especially as it pertains to diseases in which we have clinical trials for. | We are looking for partners to complement the advanced clinical care we are providing to our patients. Whether it be through data/information exchange or sharing of evidence based practice approaches to delivering innovative and promising treatments. | Serious obstetric complications (maternal health);Heart attack and stroke risk;Alcohol-related health harms;Opioid overdoses; |
| Advancing a Healthier Wisconsin (AHW) Endowment within the Medical College of Wisconsin | Karen Kmetik, PhD | kkmetik@gmail.com | Milwaukee, WI | The AHW Endowment is Wisconsin's largest health improvement philanthropy. Through its partnerships, AHW is a changemaker. The AHW 5-year plan (2024-2029) includes a landmark initiative for hypertension because cardiovascular disease remains a leading cause of death and disability for our residents, as in the nation. Hence we are strongly interested in the HEROES potential heart attack and stroke risk reduction focus. | We welcome learning with others how best to structure relationships between Health Accelerators and Outcome Buyers and Investors. And we welcome learning others' experiences with solutions that combine technology, clinical care and community linkages and that center on user experience. | Heart attack and stroke risk;Serious obstetric complications (maternal health);Opioid overdoses;Alcohol-related health harms; | |
| Parsons Government Services | Kyle Braaten | kyle.braaten@parsons.us | mark.briggs@parsons.us | Chantilly, VA | At Parsons, we are committed to accelerating health innovation through our focus on health digitization, biosecurity and biosurveillance, and research support services. In the realm of health digitization, we leverage cutting-edge technologies such as AI/ML for tech integration and cloud-based Dev/Ops. We're also heavily invested in electronic health records and Internet of Health (IoH) connectivity and analytics. In terms of biosecurity and biosurveillance, we offer solutions for early warning systems for biological threats using tools like DetectWise™. We provide scientific diplomacy, treaty compliance monitoring, capacity building in infrastructure/logistics, training/exercise programs, HVAC/Env monitoring as part of our comprehensive approach. For research support services, we deliver top-tier tech to PhD wrap around services including pre-clinical trial management and clinical trial management. | Parsons Corporation seeks partners who can benefit from our robust project management and system integration capabilities, especially in the context of large, complex program integration. We aim to find partners with products and services that can be integrated with our platforms for broad application to federal health and bioscience clients. Our unique skill of project management and technology coordination brings value to opportunities that struggle to adopt rapidly emerging technology. We offer a cloud-based Dev/Ops environment for tech integration, bringing scalable solutions that meet the needs of large programs with national or world implementation challenges. Our approach is designed to leverage prime roles and some subcontractor roles, bringing our unique skills to the forefront. | Heart attack and stroke risk;Alcohol-related health harms;Serious obstetric complications (maternal health);Opioid overdoses; |
| Varyn Consulting | Mindy Hangsleben | mindy@varynconsulting.com | Minneapolis, MN | We use quality improvement methodologies to streamline the implementation of solutions to healthcare challenges with an emphasis on health equity. We provide a tiger team that facilitates the engagement of customers and stakeholders to turn their ideas into action for the people they serve. We apply hypothesis-driven research, testing and data analysis to evaluate and design high-impact, mission-aligned concepts and solutions. We anticipate barriers to adoption and provide insight, connections, and processes for validating concepts to maximize their reach and impact. Our background and expertise include clinical care, nursing informatics, Human Centered Design, ethnographic and mixed methods research, electronic Clinical Quality Measures, value-based care payment models, Health IT implementation using participatory design and usability testing. Our team of clinicians, behavioral scientists, and engineers serves as an effective translator between patients, frontline clinicians, strategic planners, and technologists in the development and implementation of new software products and care delivery models. We help bring the voice of the customer to the forefront to enable our partners to build solutions that are appropriate and effective. | We want to partner with organizations who want to utilize behavioral science and improvement methodologies to rapidly iterate on solution designs before release and after their adoption, to foster sustainability and effective integration of HRSN/SDOH data, FQHC’s, CBO’s, and community health workers. | Alcohol-related health harms;Heart attack and stroke risk;Opioid overdoses;Serious obstetric complications (maternal health); | |
| ColigoMed Inc | Naidu Annamaneni | anaidu@coligomed.com | nobadbugs@gmail.com | Sunny Vale, CA | Hospital at a home with reduction in hospital readmission based on gen AI. Our focus areas are Metabolic health, virtual cardiac rehab and virtual wound care based on metabolic health platform. More about the company ColigoMed is a gen AI based digital health platform startup established in Dec 2020 based in the Bay Area, California, for care continuum with connected experiences between patients and providers. The platform is EMR and device agnostic that has already integrated to all top EMR systems, health exchanges, and several fitness and health tech devices. Offers patient engagement, integrated care, wound care and rehab products powered by gen AI. | We would be looking at hospital/health systems and health plans to be our customers. Potential investors to accelerate our R&D efforts. | Heart attack and stroke risk;Serious obstetric complications (maternal health);Opioid overdoses;Alcohol-related health harms; |
| Center for Health Incentives and Behavioral Economics at the University of Pennsylvania | Kevin Volpp, MD, PhD | volpp70@wharton.upenn.edu | joellef@pennmedicine.upenn.edu | Philadelphia, PA | CHIBE is the leading scientific organization using behavioral economics to improve health. Drawing on the expertise of faculty from across the University of Pennsylvania and other leading institutions, CHIBE conducts behavioral economics research aimed at reducing the burden of disease from major public health challenges and to advance health equity both in the United States and worldwide. Our mission is to advance the science of applied behavioral economics in pursuit of knowledge, interventions, and policies that lead to higher-value health care, equal access to health care, and healthier lives for all. Our team at CHIBE has been testing innovative interventions to reduce ASCVD risk, culminating with the development of the Penn Medicine Healthy Hearts program, which leverages user-friendly remote monitoring technologies to connect with patients, behavioral science strategies to increase enrollment and ongoing engagement, centralized support services using non-clinician navigators with clinician backup, and platform software tools integrated into the electronic health record. The Healthy Hearts program can be readily deployed in a geographic region and subsequently scaled more broadly with interested partners. | Outcome buyers and/or investors | Heart attack and stroke risk;Alcohol-related health harms;Opioid overdoses;Serious obstetric complications (maternal health); |
| KMASS Solutions | Keith McGuire | keith@kmasssolutions.com | HR@kmasssolutions.com | Baltimore, Maryland | Supporting a data-driven population healthcare network initiative to improve community health and planning through disease prevention, detection, and management at the earliest possible disease or outbreak stage for underserved communities. As well as project management experience and access to community-based organizations / stakeholders within the Baltimore County and extended areas within the State of Maryland to support the underserved populations. | Looking for partners that can bring innovative, technical and data driven analytical solutions. Partners who are adaptable and flexible. This includes the ability to respond to changing circumstances and adjust strategies as needed. Commitment to quality and excellence and a commitment to ethical standards, quality, and long-term objectives. | Serious obstetric complications (maternal health);Opioid overdoses;Heart attack and stroke risk;Alcohol-related health harms; |
| Your Health Kiosk | Sabiha Hussain, MD, MPH | hussaisa@rwjms.rutgers.edu | dg777@rwjms.rutgers.edu | New Brunswick, NJ | Your Health Kiosk (YHK) is dedicated to enhancing access to healthcare, particularly for underserved populations. YHK recruits its users at community events, like health fairs, hosted by community partners. After registering onto YHK, users receive health information from SMS automation and trained bilingual patient navigators respond to any requests sent over text message through the real-time chat application. Using this real-time chat application, patient navigators can connect users to other people on our platform, including social workers, community partners, and providers. A pilot study in the process of publication found that within its first year since launch, YHK reached over 600 users in New Brunswick, New Jersey, and facilitated many referrals to health services, social services, and cancer screening. Notably, most of its users were Spanish-speaking Hispanics, a historically marginalized group with disproportionally worse health outcomes in areas such as cancer. Through ARPA-H, YHK aims to pioneer an open-source multilevel intervention platform, enabling any institution to use and contribute to a library of tools to improve access to healthcare. | We are interested in partnering with collaborators who can contribute to our technology, specifically developing an application for mobile devices with the capacity to upload and share educational materials for patients and providers. Additionally, we are looking for outcome buyers within New Jersey who are committed to investing in innovative health solutions that demonstrate tangible benefits for communities. Finally, we aim to sponsor entities interested in implementing YHK technology within their own communities, leveraging our platform to improve access to healthcare. | Serious obstetric complications (maternal health);Alcohol-related health harms;Opioid overdoses;Heart attack and stroke risk; |
| IQVIA Government Solutions Inc. | Rosenie Thelus, PhD, MPH | Rosenie.Thelus@IQVIA.com | Marcine.Snyder@IQVIA.com | Falls Church, VA | IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical research services for government and the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through our analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling our customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 90,000 employees working across multiple clinical and therapeutic areas, epidemiology, data science, AI/ML, IQVIA conducts operations in more than 100 countries. | IQVIA can collaborate with Health Accelerators to target patients and tailor timely, effective interventions that power measurable improvements for selected outcomes. Data: IQVIA has access to 1B+ patient records and 26M+ healthcare professionals across various healthcare settings. IQVIA’s payer-agnostic longitudinal prescription data cover over 94% of retail outlet prescriptions dispensed across the U.S. with minimal lag time (<2weeks). These data can monitor trends in dispensing controlled substances and access to medications for opioid use disorder (MOUD) at the ZIP-3 level (https://www.cdc.gov/drugoverdose/rxrate-maps/buprenorphine.html). IQVIA’s open and closed claims capture 200M+ people per year with minimal lag time (1-2 months). These data provide national coverage of inpatient and outpatient encounters to monitor trends in various health conditions. They also capture occurrences of SOCs over time for all payer types and provide greater insights of geographic variability at the ZIP-3 level. Analytics: IQVIA brings scientific expertise in public health, statistics, and epidemiology with deep experience in identifying key modifiable drivers for opioid overdoses and SOCs. Using IQVIA’s award-winning AI and NLP methodologies that have been validated on over 150 diseases, IQVIA can identify patients at risk for undiagnosed or misdiagnosed conditions, understand risk of disease progression, identify adverse events, and much more. | Serious obstetric complications (maternal health);Opioid overdoses;Heart attack and stroke risk;Alcohol-related health harms; |
| Battelle Memorial Institute | Denise Johnson | johnsond2@battelle.org | geppertj@battelle.org | Columbus, OH | We are pleased to represent a partnership of two community-based entities in Central Ohio: Health Impact Ohio and Battelle Memorial Institute. Battelle is an independent, non-profit science & technology organization. Health Impact Ohio is a Regional Healthcare Improvement Collaborative. Our research focus area is the Central Ohio Pathways Hub, which is a care coordination program connecting at-risk populations with local care and services and operated by Health Impact Ohio in nine counties since 2019. The Hub provides pathways based on an individual person’s needs such as social service referrals, education, medical referrals, pregnancy services, and medical home services. Implementation of the pathways and connecting with persons is the role of our network of local Care Coordination Agencies (CCAs). These agencies employ Community Health Workers (CHW) which are trained and certified by Health Impact Ohio. CHWs are experts at connecting persons with quality care and services to address the risks unique to each individual and situation. Health Impact Ohio is working with partners across Ohio on a Center for CHW Excellence to support the CHW workforce. The Hub is particularly effective in improving challenging outcomes for hard-to-reach populations. https://www.healthimpactohio.org/central-ohio-pathways-hub. | While there is substantial infrastructure for Hub implementation in place, accelerating and scaling an otherwise effective intervention and applying that intervention to the HEROES outcomes would require additional teaming partners in pathway development, Community Health Worker (CHW) training & certification, health information exchange and digital health technology for data interoperability and analysis, and potentially engagement with other communities that might be interested in adapting this model. The Central Ohio Pathways Hub process consists of five steps: find & engage, assess risks, plan & connect, monitor progress, and pathway completion & reimbursement. One reason for the success to date is that this process applies across a wide variety of health care and social care service delivery models – including emerging retail models - there is no wrong door and there is no duplication of effort. There are teaming partner opportunities at each of these steps to provide either in-kind or financial support. The Hub might be a template to accelerate and scale preventive care efforts in communities across the nation for broad population health impact. | Serious obstetric complications (maternal health);Opioid overdoses;Heart attack and stroke risk;Alcohol-related health harms; |
| Charm Economics | Adam Block | adam@charmeconomics.com | chelsea@charmeconomics.com | Port Washington, NY | Charm Economics is a boutique, Harvard trained health economics evidence generation firm that develops return on investment (ROI) and evidence development predictive modeling. In-home visits will be conducted to build a database of qualitative metrics about patients and their home life that can be used in a predictive model to optimize the identification of patients in need of care management to prevent avoidable ED visits and readmissions. Qualitative data must be matched to future claims data related to outcomes. | In seeking partners within the realm of healthcare accelerators and payer entities, we are prioritizing collaborators who possess a nuanced understanding of the intricate landscape of healthcare compliance, data analytics, modeling, and evaluation. Our ideal partners will bring to the table a wealth of expertise in navigating the complex regulatory frameworks governing healthcare, ensuring that our initiatives adhere to stringent compliance standards while optimizing operational efficiency. Furthermore, we are eager to collaborate with partners who have a proven track record in harnessing the power of data analytics and modeling to drive informed decision-making and innovative solutions within the healthcare domain. The ability to leverage advanced analytics tools and methodologies will be instrumental in uncovering actionable insights, improving patient outcomes, and streamlining processes across the care continuum. Additionally, we are seeking partners with robust evaluation capabilities, enabling us to rigorously assess the impact and effectiveness of our joint initiatives, ultimately driving continuous improvement and refinement. By forging alliances with healthcare accelerators and payer partners possessing these critical capabilities, we aim to catalyze transformative change, enhance healthcare delivery, and ultimately improve the well-being of patients and communities. | Heart attack and stroke risk;Opioid overdoses;Alcohol-related health harms;Serious obstetric complications (maternal health); |
| Unite Us | Michael Tutem | michael.tutem@uniteus.com | read@uniteus.com | NY, NY | Unite Us delivers a digital infrastructure of networked community based organizations to provide care in order to address the Social Determinants of Health. Generating health equity by involving the community in parallel to access to clinical care has demonstrated tremendous outcomes across America. Specifically, Unite Us has worked with coalition partners to deliver similar outcomes across all four domains identified in the HEROES program. Unite Us empowers organizations to predict social needs at both a population and individual level to empower programs with prescribed efforts to deliver equitable outcomes. Through our core technology, coalition partners are able to screen and deliver services in a manner that empowers a longitudinal view of social care. | Health accelerator Coalition leads or “Primes” that are interested in expanding their reach to include SDoH capabilities, specifically for social needs screening, community access & development, and outcome data via closed-loop network referrals. SDoH plays a major role in all 4 designated health outcomes and we’d like to team with any Coalitions that are interested in coordinating whole-person care. | Serious obstetric complications (maternal health);Opioid overdoses;Alcohol-related health harms;Heart attack and stroke risk; |
| Boston Medical Center | Amy Perlack | amy.perlack@bmc.org | Boston, MA | Boston Medical Center (BMC) is a private, not-for-profit, 487-bed, academic medical center and the largest safety net hospital in New England, with approximately 73% of our patients coming from low-income and under-resourced populations. The hospital is the primary teaching affiliate for Boston University Chobanian and Avedisian School of Medicine. BMC emphasizes community-based care, with a mission to provide consistently accessible health services to all. Our caregivers are leaders in their fields across 70 medical specialties and subspecialties. We are an active, thriving incubator for models and programs designed to scale rapidly and address urgent public health needs and systemic barriers at a local, regional, and national level; many of our programs have been replicated nationally. BMC has a diverse research portfolio, with $82 million in sponsored research funding. It is ranked 2nd for NIH funding among safety net hospitals and in the top 20 for NIH funding among independent hospitals nationwide. Through our Health Equity Accelerator, we are working to transform healthcare to eliminate gaps in life expectancy and quality of life among different races and ethnicities. | BMC is open to serving as part of a prime performer's proposal, as a sub-awardee, on proposals that have selected Massachusetts and/or Boston as the target geographic area. | Serious obstetric complications (maternal health);Opioid overdoses;Heart attack and stroke risk;Alcohol-related health harms; | |
| Agile HMS | Rosalinda Darwin-Tiemann | rgdt@sophiaspeira.com | Durham, North Carolina | Demonstrating the social economic value of early detection and mitigation of health risk. | Access to care providers that are relevant to any of the four outcomes of the Heroes program. | Serious obstetric complications (maternal health);Heart attack and stroke risk;Opioid overdoses;Alcohol-related health harms; | |
| Arizona State University | Michelle (Lani) Shiota | lani.shiota@asu.edu | lara.ferry@asu.edu | Tempe, AZ | ASU's Substance use and Addiction Translational Research Network (SATRN@ASU) is a collective of academic researchers, community-based providers, and policy-makers dedicated to reducing death and distress linked to substance use disorder. Our activities include a high-impact seed grant program for community-engaged collaborative research, as well as annual meetings and a variety of training and dissemination initiatives. We have strong connections with regional public health agencies (City of Phoenix, Maricopa County), and several of us (including myself) have been closely involved with strategic planning around deployment of the opioid settlement funds in the decades ahead. Our early-stage idea for an ARPA-H project, supporting social determinants of success in OUD prevention and treatment, has emerged from this work. SATRN includes world-class expertise in alcohol use prevention and AUD treatment as well; should that outcome be selected by ARPA-H, we are prepared to pivot to a project addressing that topic. For more, see our website at satrn.asu.edu. | We are primarily interested in connecting with interested investors and outcome buyers interested in supporting this project; however, we also welcome outreach from additional potential regional partners in implementation. | Opioid overdoses;Alcohol-related health harms;Serious obstetric complications (maternal health);Heart attack and stroke risk; |
| ixlayer | Poorya Sabounchi | poorya@ixlayer.com | San Francisco, CA | ixlayer is a pioneering cloud-based platform dedicated to enhancing healthcare accessibility by facilitating at-home lab testing. Our collaboration with a range of organizations aims to bridge care disparities, offering essential testing services for heart health, diabetes, cancer screening, chronic conditions, and beyond. ixlayer empowers health plans, retailers, and biopharmaceutical companies with accessible, affordable, and highly credible diagnostic laboratory testing programs. Our commitment is rooted in elevating access to lab tests, which in turn boosts compliance rates and patient satisfaction. Our research agenda is focused on showcasing the tangible benefits of our seamless, patient-centric at-home testing model. For instance, our collaboration with LA Care illustrates a compelling return on investment, demonstrating a minimum of 3:1 ROI by addressing care gaps in diabetic populations. Further, our platform's facilitation of easier access to lab testing has been shown to significantly enhance testing compliance and patient satisfaction. By improving testing access and patient education, ixlayer plays a crucial role in advancing disease awareness, thus enabling better access to appropriate therapeutic interventions and treatments. ixlayer remains dedicated to demonstrating how our innovative approach can transform patient outcomes and streamline healthcare delivery. Aligned with the ARPAH mission, we believe our partnership could drive significant strides in public health innovation. | Our initiative is strategically designed to enhance care outcomes and bridge the healthcare divide for individuals at elevated risk of heart disease and stroke. Leveraging the ixlayer at-home lab testing platform, we aim to broaden lab testing accessibility for these high-risk groups. By facilitating at-home testing for key indicators such as HbA1c, Glucose, Total Cholesterol, LDL, HDL, Triglycerides, eGFR, Urine Creatinine, and Urine Microalbumin, our program endeavors to ensure timely and appropriate care for patients in need. To amplify the impact of our objectives, we seek partnerships that provide: - Access to a Medicare and/or Medicaid patient demographic identified at higher risk for heart disease or stroke, including those already diagnosed. - A shared-value financial model with ixlayer, rewarding demonstrable outcomes and cost efficiencies. - Collaboration with retail pharmacies to facilitate a test-to-treat pathway, where ixlayer manages testing and partners with pharmacies for medication dispensing. - A commitment to swift program implementation and the agility to adapt to evolving needs. Our approach is not just about improving access to testing - it's about creating a cohesive ecosystem where at-risk patients receive the care they need efficiently and effectively. | Heart attack and stroke risk;Serious obstetric complications (maternal health);Opioid overdoses;Alcohol-related health harms; | |
| CEOc (Louisville Healthcare CEO Council) | Josh Williams, VP of Strategic Initiatives | jwilliams@theceoc.com | jbristow@theceoc.com | Louisville, KY | CEOC exists to foster collaboration in the healthcare sector to advance innovation, economic vibrancy, and better health outcomes for all. This includes dissecting challenges throughout the healthcare industry; distilling those challenges into actionable problem statements; and then identifying, championing, and validating new interventions (technological, process, and medical) within a variety of care settings across the continuum. One of the topical areas we're interested in is realignment of the healthcare system to one that is proactive in keeping individuals healthy and aligning incentives to sustain that type of disruption. | We're looking to partner with other organizations who are catalyzing the healthcare industry at a systems level to improve healthcare outcomes (specifically within the context of preventative care). Our scope looks not only at the impact of an intervention at the point-end of the solution; rather, seeks to understand the upstream and downstream effects of the intervention across the care continuum to model how it may be a scalable solution. | Serious obstetric complications (maternal health);Opioid overdoses;Alcohol-related health harms;Heart attack and stroke risk; |
| Senscio Systems | Tom Arneman | tarneman@sensciosystems.com | gclouse@sensciosystems.com | Boston MA | Senscio’s Ibis program provides virtual, whole person care, for patients managing complex health resulting from comorbidities from diseases including HTN, AFIB, DM, HLD, CHF as well as mental health illnesses. Senscio’s proprietary Digital Twin model, designed by leading clinicians, creates an individualized care plan, integrating an individual’s medical history, medication adherence, vital monitoring and behavioral preferences. This twin provides a baseline to manage deviations in a member’s health. Based on this digital representation, Senscio proposes to refine and research the effectiveness of disease specific "Self-Management” protocols for HTN, Hyberglycemia, Hypoglcemia, and CHF. The goal of the research will be to deploy and measure the effectiveness of Senscio’s cardiovascular self-management protocols, reducing the need for services to reduce hospitalizations while empowering members to remain healthy at home. In addition to the protocols themselves, a new commercial model is needed to incentivize “Self-Management” innovation. In the current business model, Digital Twins trigger Senscio’s Medicare covered services to address members health needs. While the current program is effective, demonstrating 37% reduction in hospitalizations, Senscio proposes to collaborate on commercial model to scale Digital Twin based, automated, self-management for members with complex health. | The ideal Teaming Partner would be a health plan focused on care for 65+ population with complex health. The partner would support the development and deployment of Senscio’s Self -Management program to insured beneficiaries. This scope would include: - Review and input to “Self-Management” protocols and Digital Twin models - Design of research study demonstrating health outcomes and reduced cost of care - Identification of eligible population of members with complex health Program co-marketing of program to eligible population including email and outbound recruiting - Collaboration to design an outcomes based commercial model Senscio will supply the overall structure including program management, clinician input, overall technology and Digital Twin model. | Heart attack and stroke risk;Alcohol-related health harms;Opioid overdoses;Serious obstetric complications (maternal health); |
| Fund for Public Health NYC | Sara W. Gardner | sgardner@fphnyc.org | jricci@health.nyc.gov | New York, New York | FPHNYC is the 501(c)(3) affiliate to NYC Department of Health and Mental Hygiene (DOHMH) and the only organization dedicated solely to working with the NYC DOHMH to serve the needs of New York's 8.5 million residents. DOHMH is one of the nation's oldest public health agencies, with more than 200 years of leadership in the field. With DOHMH’s leadership, NYC launched HeathyNYC with the goal of setting out a vision for how New York City can drive cross-sector resource mobilization and health decision making to achieve longer, heatlhier lives. HealthyNYC identifies key direct drivers of life expectancy in NYC, including goals for reducing overdose deaths by 25% by 2030 and decreasing maternal death rates by 10% by 2030. To achieve these goals, DOHMH is organizing the implementation of priority evidence-based strategies for each of these drivers, including close cross-agency collaboration and cross-sector external partnerships to drive impact at scale. | FPHNYC is interested is networking with potential investors or outcomes buyers that want to invest in population health in NYC. | Opioid overdoses;Serious obstetric complications (maternal health);Heart attack and stroke risk;Alcohol-related health harms; |
| Amalgam Rx | Sara Silacci | ssilacci@amalgamrx.com | nateweiner@amalgamrx.com | Wilmington, DE | We work with provider systems and life sciences companies to develop patient support applications or regulated SaMD products that drive positive outcomes and change lives. Powered by insights from billions of proprietary data points, we’re delivering insights derived from over 10 million longitudinal patient records. Integrated seamlessly into the EHR, our solutions enable patient identification, clinical trial recruitment, care guidelines, financial assistance, and more—all within the provider workflow. | We are looking to team with a Health Accelerator, particularly health systems, to address any of the clinical outcomes below. | Opioid overdoses;Heart attack and stroke risk;Serious obstetric complications (maternal health);Alcohol-related health harms; |
| Florida Department of Health in Orange County | Dr. Robert Karch | Robert.Karch@flhealth.gov | Sandra.Frazier@flhealth.gov | Orlando Florida | The Florida Department of Health in Orange County (DOH-Orange) is focused on reducing the risk of heart attack and stroke. Heart disease is the leading cause of death in Orange County and Stroke is the fourth leading cause of death in the county. | DOH-Orange seeks to partner with other organizations focused on reducing the risk of heart attack and stroke to significantly improve population health in Orange County Florida. | Heart attack and stroke risk;Serious obstetric complications (maternal health);Opioid overdoses;Alcohol-related health harms; |
| CAD Therapeutics | Sara Silacci | sara@margin4mission.com | cteas@cadtherapeutics.com | New York, NY | CAD owns the Patent for the SGB injection Method using the Drug CLONICAINE. CLONICAINE is composed of two APIs - Bupivacaine and Clonidine. CLONICAINE is not yet an approved FDA drug on-label for the treatment of OUD and PTSD. We are currently conducting trials to secure FDA approval for these indications. | We are looking to team with a Health Accelerator to provide treatment for patients with OUD and at risk for overdose. | Opioid overdoses;Alcohol-related health harms;Serious obstetric complications (maternal health);Heart attack and stroke risk; |
| sparks & honey | Robb Henzi | robb.henzi@sparksandhoney.com | kristin.cohen@sparksandhoney.com | New York, NY | Our research extends across US-focused, multi-market and global research efforts, covering both the population at-large and specific consumer segments/demographics. Our research topics include (non-exhaustive): Precision Consumer 2030, Connected Care, Personalized Medicine, Digital Twin Trials, Virtual Rehab, Neurodegenerative disease previvor, Health Equity as well as the application of foresight methodologies onto larger healthcare category questions. Recent U.S. government included the exploration of topics including: healthcare taboos, mental health, health equity, always-on diagnostics, at-home care, and a variety of other topics. | The types of organizations we believe could be a great and complementary addition include those with expertise in areas including: Diversified Health Equity Topics, Technological Execution, Local Program Rollout. | Serious obstetric complications (maternal health);Opioid overdoses;Alcohol-related health harms;Heart attack and stroke risk; |
| Park South Capital | Sara Silacci | sara@margin4mission.com | cteas@parksouthcapital.com | New York, NY | We are a private equity fund that invests in healthcare and life sciences companies that aim to prevent and treat mental health conditions such as addiction, PTSD, depression, and more. We also have a philanthropic foundation that supports non-profit organizations and research addressing mental health conditions. | We intend to submit an LOI to be a Health Accelerator to address the opioid overdoses if this clinical program is selected. We would like to team with industry and provider systems. | Opioid overdoses;Alcohol-related health harms;Serious obstetric complications (maternal health);Heart attack and stroke risk; |
| Get Well | Kailin Hsu | khsu@getwellnetwork.com | ckingarthur@getwellnetwork.com | Bethesda, MD | Get Well is a leading digital health company committed to enhancing patient engagement and the overall healthcare experience through innovative technology. We are focused on improving maternal health outcomes and reducing racial inequities through a digital program that streamlines the following: health education, symptom checkers, screeners for non-medical needs, and resource navigation. Our Maternal Health Equity program spans the prenatal to postpartum continuum and is based on SMS text messaging that is delivered through a combination of automation and live human interaction from our Get Well virtual navigators. SMS text messaging is the most reliable and efficient way to reach as many birthing people as possible, particularly those who are underserved, and automation allows for scalability and efficiency. Our navigators step in when support beyond what automation can provide is needed, or to reach out to patients who do not have a textable number or who are not engaging as expected. Our program is personalized at a healthcare system-level to include education and resources specific to the healthcare system we partner with. Through our program, we have seen reductions in preterm delivery rates and NICU length-of-stay (LOS), and an increase in prenatal appointment adherence rate. | We are looking for outcome buyers or strategies for securing outcome buyers who are interested in partnering with us to use our proven method in reducing preterm delivery rates and NICU LOS and increasing prenatal appointment adherence, to explore our program’s effect on the following additional outcomes: Reducing severe obstetric complications, ED utilization rate, C-section rate, readmission rate Increasing breastfeeding rate We are also interested in working with organizations who provide innovative maternal health solutions who might not have the structure or capital to serve as a primary accelerator. | Serious obstetric complications (maternal health);Heart attack and stroke risk;Opioid overdoses;Alcohol-related health harms; |
| Aptive Resources | Kate Gorman | katherine.gorman@aptiveresources.com | yessenia.castillo@aptiveresources.com | Alexandria, Virginia | Aptive Resources is a government contractor supporting the science, health, mental health, substance use, and suicide prevention work among federal agencies. Aptive provides high level research, data analysis and evaluation, creative health solutions, strategic engagement, and digital transformation. Our research focus areas include Maternal Health and Opioid overdose reduction and alternatives. Within Maternal Health, we aim to create an easily accessible app, to include a maternal health library, and gamification for usage, telehealth options, and provider/patient communication, along with the possibility of doula/midwife support. Our opioid solution includes a Complimentary Integrative Health app, with options for medical marijuana, which has been used successfully as a prescription alternative for chronic pain, taper from opioid, and as treatment for withdrawal; and the app will include MAT training for providers and MAT options when needed. We aim to include the provider and pharmaceutical company in this health model, providing a shift in business, necessary to change the opioid crisis at the root, to CIH and medical marijuana - set to be rescheduled this year, thereby covered by insurance. | Within Maternal Health, we would like to consider pairing with a company with an established app seeking expansion of efforts within their app, or a company who will help us build from scratch. We hope to partner with companies that can support patient/provider connections in a designated region, as well as interested insurance companies or other acting as outcome buyers. For our opioid solution, we aim to partner with pharmaceutical companies to build and run the app, and to manufacture medical marijuana. We are seeking medical organizations and opioid education alliances to support the integration of the app within a region, recruiting doctors to become prescribers on the app. We are additionally seeking insurance companies and possibly states receiving settlement money to become outcome buyers. | Opioid overdoses;Serious obstetric complications (maternal health);Heart attack and stroke risk;Alcohol-related health harms; |
| Department of Epidemiology, Boston University School of Public Health | Collette Ncube | ncube@bu.edu | Boston, MA | I am an academic with research expertise in maternal and infant health. My research focuses on the social and structural drivers of racial and ethnic disparities in perinatal health. I am partnering with the Massachusetts League of Community Health Centers (the Health Accelerator) to affect change in Massachusetts with a particular interest in addressing racial and ethnic disparities in maternal health outcomes. | We am seeking partners (outcome buyers and investors) in Massachusetts with whom to engage in co-developing a proposal to address maternal health and cardiovascular health within the population of pregnant and postpartum individuals. | Serious obstetric complications (maternal health);Heart attack and stroke risk;Opioid overdoses;Alcohol-related health harms; | |
| Maternal+ | Adriana Soto Ospina | adriana.soto@maternal.app | kellyn.rodriguez@progressus.com.co | Miami FL | Maternal+ is dedicated to transforming maternal healthcare for underserved Hispanic women by leveraging telemedicine and culturally competent care. Our research is centered on several key areas: pioneering telehealth technologies to enhance prenatal and postnatal care accessibility; tailoring healthcare services to the cultural and linguistic specifics of the Hispanic community; integrating mental health services within maternity care to improve outcomes and reduce postpartum depression rates; addressing barriers to healthcare access due to socio-economic, immigration, and language challenges; and rigorously measuring the impact of our interventions on maternal and neonatal health. By focusing on these areas, we aim to identify and implement effective strategies that not only improve the quality and accessibility of healthcare for Hispanic women but also contribute to closing the health equity gap. Our goal is to produce evidence-based insights that can inform healthcare providers and policymakers, ensuring that maternal healthcare services are both inclusive and effective. Through this comprehensive approach, Maternal+ is at the forefront of research and innovation in maternal healthcare, striving to ensure that every Hispanic woman receives the care she deserves during one of the most critical times of her life. | Maternal+ seeks teaming partners who share our commitment to advancing maternal healthcare for underserved Hispanic women, with a particular focus on leveraging telemedicine and culturally competent care. Ideal partners would bring expertise in healthcare technology, digital content creation, and community engagement, enriching our platform with innovative solutions and compelling narratives that resonate with our audience. We value collaborators who have a deep understanding of the healthcare challenges faced by the Hispanic community, including those with experience in mental health, prenatal and postnatal care, and health equity advocacy. Additionally, partners with a strong track record in research and data analysis are crucial, as we aim to continually measure and improve the effectiveness of our interventions. Organizations that are creative, adaptable, and passionate about making a tangible difference in the lives of Hispanic women and their families are especially welcome. We look for partners who are not just looking for a transactional relationship but are interested in building a long-term collaboration that amplifies our impact and contributes to a legacy of improved maternal health outcomes. Ultimately, our goal is to form a coalition of like-minded entities that can collectively drive innovation, access, and equity in maternal healthcare. | Serious obstetric complications (maternal health);Heart attack and stroke risk;Opioid overdoses;Alcohol-related health harms; |
| TACHC Clinically Integrated Network LLC | Franchella Jennett | fjennett@texascin.com | jeubank@tachc.org | Austin, Texas | TACHC Clinically Integrated Network LLC was established by Texas federally qualified health centers and the Texas primary care association (TACHC) to enhance health centers' participation in value based care and alternative payment models. We are a network of 49 health centers across the state with the goal of improving health outcomes for the communities we serve. | We are interested in connecting with outcome buyers, investors and others that are passionate and aligned with the health center mission and model. In understanding our model, we can best collaborate on high impact for the outcome measures. We are also interested in partnerships that have connections to Texas and increasing sustainable well-being in our communities. | Heart attack and stroke risk;Serious obstetric complications (maternal health);Opioid overdoses;Alcohol-related health harms; |
| Georgetown - Howard Center for Medical Humanities and Health Justice (MHHJ) | Alisa Byers | alisa.byers@georgetown.edu | info@mhhj.org | Washington, DC | A historic partnership between Georgetown and Howard, the Center for Medical Humanities and Health Justice fosters learning, research, and public engagement at the intersection of humanities and healthcare in Washington, DC. Our vision is informed by our belief in the humanities’ ability to improve people’s lives, to improve healthcare training, and, by extension, health outcomes, to help us better understand the human condition. Our research focus areas include mental health, health services access, and alternative measures for health. | MHHJ is seeking teaming partners believe that a humanist approach to healthcare is what will influence permanent behavioral change in a community. MHHJ has a network of community organizations, academic scholars, and medical practitioners who can support amplifying the stories of the Washington, DC area residents, to distinguish the context and experiences from generalized health system data. | Alcohol-related health harms;Serious obstetric complications (maternal health);Heart attack and stroke risk;Opioid overdoses; |
| University of Massachusetts Chan Medical School | Allan Walkey | allan.walkey1@umassmed.edu | elizabeth.krauza@umassmed.edu | Worcester, MA | We represent programs across UMass Chan Medical School, including the Division of Health Systems Science, Department of Population and Quantitative Health Sciences, and the Department of Healthcare Delivery and Population Sciences at Umass Chan-Baystate. Our research programs span Population Health, Digital Medicine, Research Informatics, and Learning Health Systems, using qualitative, quantitative, and mixed methods. We drive health system improvements at the intersection of clinical care and research, with expertise that addresses both medical and social drivers of health across each of the HEROES outcomes areas. For example, for the ARPA-H HEROES ASCVD risk outcomes, our interventions include a multi-faceted toolkit that pools electronic health record to automate identification of patients with the largest potential for improvement in ASCVD risk, uses AI-based tools to triage patients to lifestyle medicine interventions (community-based food-as-medicine and dietary counseling, smoking cessation, social connection, and exercise programs), primary care-digital health linked preventative medication optimization, and connects patients eligible for specialty drugs (such as GLP1-agonists) and medication adherence support in our advanced therapeutics program. Similarly, for opioid overdose outcomes, we leverage our expertise in implementing evidence-based interventions (e.g., connection to MOUD and MISSION interventions combining behavioral therapy and SDOH interventions) scaled to at-risk populations. | We look forward to Teaming with Investors and Outcome Buyers to accomplish the HEROES outcome goals. We seek both investors (AI-based triage to resources, lifestyle medicine programs, health centers and systems) and outcome buyers (payors, unions, employer groups) to partner with us to deliver our toolkit across Massachusetts. | Heart attack and stroke risk;Opioid overdoses;Serious obstetric complications (maternal health);Alcohol-related health harms; |
| Rochester Regional Health | Deepa Patel | deepa.patel@rochesterregional.org | Nichole.MalecHuss@rochesterregional.org | Rochester, New York | Leveraging novel technology services to manage patient processes, implement remote patient monitoring, increase cross-provider communication, and integrate seamlessly with the Electronic Health Record (EHR) will reduce the aggregate 10-year risk of heart attack and stroke for people age 40-70 years, lower readmission rates in the cardiovascular disease population, facilitate patients’ ability to stay in their homes thus reducing health care burden, and decrease the overall cost of care for these patients. | Payers, start-ups, other health systems, government agencies | Heart attack and stroke risk;Serious obstetric complications (maternal health);Opioid overdoses;Alcohol-related health harms; |
| Maycomb Capital | Shelby Kohn | skohn@maycombcapital.com | rsubramanian@maycombcapital.com | Brooklyn, NY | Maycomb Capital’s Community Outcomes Fund invests in health and human service projects for low-income and underserved populations, with a focus on health equity. We have supported projects across the country that address maternal health, early childhood development, the direct care workforce, and other social determinants of health. | We are looking for the following in teaming partners: - Track record of delivering tangible results in the ARPA-H outcome areas, particularly in low-income and underserved communities - Commitment to robust performance management, including metrics that demonstrate an individual’s progress towards better health outcomes and project milestones - Experience working with a variety of project partners, including private health systems, Outcome Buyers, and public entities - Interest in outcomes financing to support service delivery, as well as the financial position to support a working capital loan | Serious obstetric complications (maternal health);Opioid overdoses;Heart attack and stroke risk;Alcohol-related health harms; |
| Healthy Brains Global Initiative | Andrew Hatfield | andrew.hatfield@hbgi.com | shomsia.ali@hbgi.org | 100% remote, international presence. US staff based in East and West coast | Outcomes fund management, Results Based Contracting, and Performance Management for (primarily) mental health initiatives. We can take your strategy, run discovery, contract and program design, implement, and performance manage to your desired outcomes. | 1) Donors looking to optimize performance of their funds through Results Based Contracting and performance management of service providers. 2) Organizations seeking Technical Assistance in managing downstream service providers through Results Based Contracting and/or Performance management | Opioid overdoses;Alcohol-related health harms;Serious obstetric complications (maternal health);Heart attack and stroke risk; |
| Institute for Healthcare Improvement (IHI) | Valerie Spalding | vspalding@ihi.org | canderson@ihi.org | Boston, MA | The Institute for Healthcare Improvement (IHI) is an independent non-profit organization based in Boston, Massachusetts, USA. For more than 30 years, IHI has used improvement science to advance and sustain better outcomes in health and health care across the world. IHI brings knowledge and skills in quality improvement and safety sciences to millions, catalyzes learning and the systematic improvement of care, develops solutions to previously intractable challenges, and mobilizes health systems, communities, local governments, funders, and nations to reduce harm and deaths. IHI collaborates with a growing network of institutions and individuals to spark bold, inventive, and dynamic ways to improve the health of individuals and populations. IHI’s focus areas are safety, effectiveness, equity, and systems resilience. IHI strives for a future free of health inequities and commits its tools, talents, and teams to this essential human pursuit. IHI collaborates with institutions, leaders, managers, teams, and individuals to build more robust systems that make access to care, diagnosis, treatment, and health outcomes safer, more accessible, more reliable, and more equitable. IHI works with institutions across the entire health ecosystem, including health care, public health, and social care. Learn more at www.ihi.org. | The Institute for Healthcare Improvement (IHI) is seeking to join the consortium or teaming partnership of a Health Accelerator with jurisdiction over a densely populated urban area with communities in need of the transformational improvement in health outcomes envisioned by ARPA-H. The ideal Health Accelerator consortium would have strong convening power with a wide range of stakeholders across the care continuum from community through outpatient clinical and behavioral health to inpatient health services. Access to longitudinal disaggregated data on clinical and population health outcomes for the communities the Health Accelerator serves would also be critical for the success of the consortium. IHI seeks to contribute the following expertise to the consortium or teaming partnership: capability building in improvement science methods and tools; longitudinal coaching of teams towards improved performance; collaborative learning and facilitation; learning system development and integration; designing for scale and sustainability; and implementation support. IHI is also interested in speaking with any interested funders, including payers, who might be interested in working together to achieve improved outcomes for their beneficiaries and constituencies. | Serious obstetric complications (maternal health);Heart attack and stroke risk;Opioid overdoses;Alcohol-related health harms; |
| North Sound Accountable Community of Health (North Sound ACH) | Emily Blue | Grants@NorthSoundACH.org | Emily@NorthSoundACH.org | Bellingham, WA | North Sound Accountable Community of Health exists to create a just and inclusive culture and the necessary conditions for all community members to thrive. We work with clinical and community partners across five counties and eight tribal nations to support local and regional approaches to advance equitable well-being. With a focus on racial and social justice, we take a broad view of health and look beyond traditional care models to address the root causes of disparities. We partner with a wide network of organizations, governments, coalitions, and leaders in order to ensure that investments in our community are well-coordinated and lead to measurable outcomes. Our current focus areas include supporting a regional care coordination hub and convening the North Sound Collaborative Action Network, a learning, advocacy, and action network with over 180 partners dedicated to creating community-centered solutions. As partners in Washington’s Medicaid Transformation Project since 2017, we have extensive experience with value-based payment models and working to transform health and community services for people on Medicaid. We recognize the need for a longer-term vision beyond the waiver-related activities and are actively working to braid philanthropic funds, community contributions, and health system investments to sustainably support our ongoing work. | We are primarily looking for partnerships with outcome buyers, and potentially with other health accelerators in Washington State. In particular we are looking for partners to help develop and further expand interoperability of our Community Hub and bridge the gap between clinical providers and community-based organizations. We currently have a robust network of more than 180 clinical and community partners across five counties and eight tribal nations. We use targeted universalism as an operational and communication framework to ensure that equity is centered in all our work, and prioritize alignment with any potential partners. We also expect partners to demonstrate a commitment to addressing the root causes of health disparities and to authentically considering the impacts of race, class, and privilege. | Opioid overdoses;Alcohol-related health harms;Serious obstetric complications (maternal health);Heart attack and stroke risk; |
| Arizona State University | William J. Riley | William.J.Riley@asu.edu | lara.ferry@asu.edu | Phoenix, Arizona | The National Safety Net Advancement Center (NSNAC) is an established knowledge center of excellence at Arizona State University (ASU). We are a diverse team of inter-disciplinary, nationally recognized scholars, researchers, innovators, practitioners, community leaders, social advocates, and data scientists, committed to improving health outcomes. Our expertise spans healthcare finance, provider contracting, risk management, population health management, quality improvement, and program evaluation. In 2023, we submitted 22 new research proposals representing $68 million in funding, resulting in 6 awards. We are the recipient of a 2024 Center award to train physicians to research and improve health outcomes within Arizona’s largest safety net health care system. We are implementing a $600 million, 10-year incentive program in partnership with Arizona’s Medicaid agency (Arizona Health Care Cost Containment System, AHCCCS) to reward primary care providers for achieving HEDIS population health process and outcomes targets. AHCCCS providers achieved greater than a 5% improvement in 7 of the 10 targeted HEDIS measures, enabled by a peer learning collaborative and real-time, actionable visualization of data dashboards. We collaborate with ASU’s Maternal and Child Health Translation Team, a high impact community of practice, working with community partners across maternal and child health research, professional development, and knowledge networks. | Maternal health outcomes spans preventative and curative care, and health and non-health services. Therefore, we will seek a team of partners with synergistic skills, covering touch-points across the full spectrum of maternal care, from pre-pregnancy to prenatal, intrapartum, and post-partum periods. As an Accelerator, we will seek Outcomes buyers and Investors, by leveraging our relations with Arizona’s Medicaid agency, the state’s largest commercial payers, and our expansive partner network of primary care, behavioral health and specialist providers. We will engage philanthropists with established relations with ASU and with interests in maternal health as potential investors. We will engage with our American Indian health care services collaborators and seek their partnership. Our partners will include traditional health care maternity systems and emerging community health care systems. We collaborated with Valleywise Health System and Dignity Health maternal health providers, to previously develop a proposal to improve Hypertensive Disorder of Pregnancy outcomes, by implementing a SDOH Equity bundle to address sub-optimal pre-natal and post-partum follow up rates. We engaged with the Arizona Hospital Association representative from the national leader in maternal care, Alliance for Innovation in Maternal Health (AIM), in developing the maternal hypertension proposal, and plan to include AIM in our team. | Serious obstetric complications (maternal health);Opioid overdoses;Alcohol-related health harms;Heart attack and stroke risk; |
| Guidehouse | Marguerite Clarkson | mclarkson@guidehouse.com | mmwilliams@guidehouse.com | McLean, VA | Guidehouse brings together public and commercial healthcare organizations, offering a 360-degree industry approach to solving our client’s most complex challenges. Our comprehensive suite of healthcare advisory, digital, and managed services drives innovation, growth, and resiliency across communities. For example, we provide strategy, change management, analytics, and program transformation services to help federal health agencies achieve their missions with sustainable success. We work with state and community health and human services leaders to help tackle public health, population health, and resiliency challenges. This includes designing workforce development strategies and deploying innovative payment models through value-based approaches. We support hospitals and health systems and help providers become more agile and financially resilient to drive better overall health for the communities they serve. We support biopharmaceutical and medical device companies with global commercial strategy and operations to accelerate growth and enhance the value of their products in the market. We help commercial and public health plans attain sustainable, digitally powered, and differentiated business models that keep people and providers engaged, improve financial resiliency, and nurture growth. | Guidehouse’s health practice is comprised of experts serving the full health continuum – from basic research to regulators, providers, payers, and population health – we help solve our clients’ most complex, mission critical problems. We are modernizing federal organizations, including components of HHS and the VA and we have deep experience enabling public-private partnerships serving rural and urban health settings. We help organizations integrate programs, implement solutions, and we connect stakeholders. We are primarily seeking partners – including public and private sector partners, academia, and health focused non-profits – that have pre-existing solutions, methodologies, or processes for the selected health outcomes, and we can help organizations scale to achieve health goals/outcomes of HEROES. We look forward to engaging with other organization who share this mission. | Serious obstetric complications (maternal health);Heart attack and stroke risk;Opioid overdoses;Alcohol-related health harms; |
| SSM Health | Susan Kendig | susan.kendig@ssmhealth.com | suekendig@gmail.com | St. Louis, MO | SSM Health areas of focus include the intersection of social/structural determinants of health and their impact on patient outcomes, specifically maternal and child health. Further, we seek to learn more about how clinical community integration efforts can further our work with medically high risk populations, such as pregnant and postpartum persons experiencing substance use disorders, and those with severe chronic or emerging conditions, such as cardiovascular disease, mental health issues, obesity and diabetes. We have several programs dedicated to these populations and seek to learn more about effective integration strategies. | We would be interested in hearing from community based partners who could support the work described above. We would also be interested in speaking with outcome buyers and at risk investors considering investments in similar work. | Serious obstetric complications (maternal health);Opioid overdoses;Heart attack and stroke risk;Alcohol-related health harms; |
| Second Hub Collaborative | Caitlyn Scales | caitlyn@upthescales.com | jgm@mentibusgroup.com | New Orleans, LA | Our organization partners with research groups or institutions who focus on cutting edge healthcare innovations. Currently, we are supporting design and funding for research in digital health integration, health disparities, data science, models of healthcare delivery, and prevention. | Our organization is looking for teaming partners who need support from registration to submission and who are looking to bring a strong team together and need strategic support to match strengths for success. Additionally, we are looking to be a strong catalyst for research teams in proposal writing and research design. | Serious obstetric complications (maternal health);Opioid overdoses;Heart attack and stroke risk;Alcohol-related health harms; |
| NOMA AI INC | Salim Malakouti | salim@noma.ai | g.clermont@noma.ai | Pittsburgh, PA | NOMA AI is developing an AI platform that analyzes multimodal medical data with machine learning to predict the risk of complications in healthcare settings. NOMA is initially focused on tackling maternal hemorrhage, the leading cause of maternal mortality and morbidity; however, the company is proactively building partnerships to address similar problems, such as postpartum hypertension and emergency care triage. | partner health systems | Serious obstetric complications (maternal health);Heart attack and stroke risk;Opioid overdoses;Alcohol-related health harms; |
| John Snow Labs | Mwisa Chisunka | mwisa@johnsnowlabs.com | Lewes, Delaware | John Snow Labs, an AI company, is the developer of Spark NLP - the most widely used NLP, LLM and VDU libraries. With 75+ million downloads to date, the library comes with 25,000+ pre-trained models in 250+ languages. John Snow Labs is also the creator of Healthcare NLP which offers 2,000+ pretrained models tailored to handle medical and clinical text data, assist in tasks such as medical entity recognition, clinical concept extraction, de-identification, adverse drug reaction detection, and more. John Snow Labs has experience developing accurate unstructured clinical text understanding pipelines that support real world evidence research, pharmacovigilance, clinical decision support, precision medicine, patient risk adjustment, population health, patient safety, and clinical trial matching systems. John Snow Lab’ Medical Chatbot provides a conversational interface to a suite of medical knowledge bases, updated daily. The Medical Chatbot designed to help experts stay current with medical research, case reports, trials, terminologies, and their organization’s private content, utilizes simple natural language interface. The chatbot provides full explainability by always citing its sources and prioritizes privacy through features like role-based access. John Snow Labs leads in responsible AI with its LangTest library, supporting over 100 test types for evaluating LLMs' safety and effectiveness. | John Snow Labs seeks collaboration with organizations that will augment our expertise in AI and NLP technologies, with a specific emphasis on preventative healthcare and public health initiatives. Ideal partners should possess a profound understanding of healthcare economics, have experience in executing large-scale health interventions, and demonstrate a successful track record in preventative care initiatives. We aim to collaborate with entities that have established networks within underserved communities, facilitating the implementation of preventative care technologies. Furthermore, partners with access to innovative funding mechanisms or connections to philanthropic, insurance, and healthcare policy sectors are sought to foster sustainable health improvements. Our objective is to utilize our AI and data analytics capabilities in conjunction with the HEROES initiative to enhance health outcomes through strategic, data-driven preventative care approaches. | Heart attack and stroke risk;Opioid overdoses;Alcohol-related health harms;Serious obstetric complications (maternal health); | |
| Purdue University | Nan Kong | nkong@purdue.edu | adams417@purdue.edu | West Lafayette, IN | Our mission is to make non-traditional health data accessible, accurate and actionable for communities and populations in Indiana and beyond which have limited access to quality care. In particular, as social determinant of health (SDoH) can significantly impact patient health outcomes, we focus on augmenting the current community health programs and operations through effective use of individual-level SDoH. We have created several software solutions for use by social workers, case managers, and clinicians to streamline the work they do with patients. These tools also help collect important non-traditional health data to be able to tie social drivers and interventions to health outcomes, data which is not found in electronic health records. By harmonizing these individual-level non-traditional data with EHR, as well as healthcare data managed by data centers, physiological, biobehavioral, self-reporting data collected through mobile sensing technologies, and administrative data shared from providers in fixed geography, we will use the software solutions to recommend programmatic and operational decisions to improve health outcomes of individuals and populations. Our focus also includes develop informatics technologies and techniques to ensure the interoperability among multiple health systems and the efficiency in collaborative learning from a population of end users. | We are looking for partners to disrupt the current system of care for maternal health and create a blueprint for localized systems of care outside of the traditional healthcare walls for improving the following outcomes, maternal mortality, infant mortality, premature birth, post-partum complications including post-partum depression, through preventive measures. We would like to have community paramedics programs and FQHCs as investors and insurers both public and commercial as outcome buyers. Particularly, we are interested in those who are willing to let us (a healthcare accelerator) to take the asset-based community development strategy for localizing evidence-based preventive measures and systems of care for each community in the fixed geography. | Serious obstetric complications (maternal health);Heart attack and stroke risk;Opioid overdoses;Alcohol-related health harms; |
| Happiest Baby Inc | Harvey Karp, MD | hk@happiestbaby.com | Fran@happiestbaby.com | Los Angeles, CA | We study the effect of advanced baby bassinets (SNOO Smart Sleeper) on infant sleep, crying, and keep sleeping babies safely on the back. care of premature infants, care postoperative, babies exposed ot opioids, long term development of infants. We also support studies on new parents looking at the bed's impact on anxiety/depression, substance use, parental self efficacy and bonding, safe sleep practices, parental exhaustion, job burnout (doctor and nurse), support of hosptial nurses in care of infants | We seek partners who work with such groups to reduce maternal complications (e.g. anxiety, depression, self harm, substance use, etc.) and ot reduce infant complications (SIDS/SUID, child abuse/neglect). Also this einterested in reducing burn out of health care providers. | Serious obstetric complications (maternal health);Opioid overdoses;Heart attack and stroke risk;Alcohol-related health harms; |
| University of Maryland | Bradley Maron, M.D. | BMaron@som.umaryland.edu | Martha Jurczak | Baltimore, MD | The University of Maryland School of Medicine (UMSOM) is a powerhouse in clinical, community health, and health disparities research, ranking at the top among all U.S. public medical schools in research funding. The UM-Institute for Health Computing integrates artificial intelligence and bioinformatics to advance population health and real-world data analytics. The Kahlert Institute for Addiction Medicine encompasses physician-scientists who pioneered evidence-based approaches to care for people who use substances. This includes active management of >800 opioid or alcohol use disorder patients, providing a critical framework for numerous high-impact clinical studies. Maternal health is also a major UMSOM research focus, which utilizes a unique community network of high-volume obstetrical centers (>10,000 deliveries annually), associated neonatal intensive care units, and the B’more for Healthy Babies Center. These collective entities are dedicated to improving maternal health through clinical research, including emphasis on cardiovascular diseases (CVD) that drive pre-term birth. Indeed, CVD is highly prevalent throughout the UMSOM patient population, leading to key academic contributions by UMSOM faculty studying the gamut of cardiac and vascular disorders. Importantly, the Electronic Health Record unifies all clinical operations, enabling pragmatic clinical studies that consider the robust and highly diverse 2 million patient population at UMSOM. | The University of Maryland ARPA-H consortium includes the University of Maryland School of Medicine (UMSOM) and University of Maryland Medical System (UMMS). This network of clinical operations comprises 15 hospitals and 77 clinics reaching >2 million patients and >17 million unique patient-encounters corresponding to granular data on ~33% of all patients in Maryland. The UMMS catchment region is strongly diverse across geographic, socioeconomic, racial, and environmental spectra. Further, existing UMSOM-community partnerships enable decentralization of accelerators to optimize disease prevention, early detection, and therapeutic deployment at the neighborhood or patient levels. This is important since UMSOM and UMMS operate within the Global Budget Revenue (GBR) model, which is a system that fixes each hospital's total annual revenue, thereby incentivizing population-based initiatives to reduce costs, promote better care, and improve health. The GBR is unique to Maryland, however other states are legislating similar policies. Therefore, the University of Maryland ARPA-H consortium is well-positioned to demonstrate value-based initiatives in a rate-regulated, capitated system and serve as a national model. We require outcome buyers and partners with experience building reimbursement strategies/policies for a wide-reaching medical system. Further, we seek partnership with additional medical systems that can enable maximal patient engagement throughout Maryland. | Opioid overdoses;Serious obstetric complications (maternal health);Alcohol-related health harms;Heart attack and stroke risk; |
| University of Louisvlle | Will Metcalf | will.metcalf@louisville.edu | Kerrigan.miller@louisville.edu | Louisville, KY | UofL's research interests span cardiovascular disease, alcohol use disorder, and maternal health. Our work on cardiovascular disease focuses on the effects of the environment and its impact on heart health. In alcohol use disorder research, we investigate the link between alcohol and cardiovascular disease, as well as the benefits of reducing alcohol intake. Our goal is to understand these relationships and improve prevention and treatment strategies. | UofL needs a diverse group of partners, including health providers, insurers, investors, and community health organizations. | Alcohol-related health harms;Heart attack and stroke risk;Serious obstetric complications (maternal health);Opioid overdoses; |
| Pima County Health Department | Britt Nigon | brittany.nigon@pima.gov | matthew.schmidgall@pima.gov | Tucson, AZ | The Pima County Health Department aims to be one of the healthiest counties in the nation by 2030. We will achieve this goal by ensuring the health, safety, and well-being of our community through leadership, collaboration, and education. | We seek partners we can work with to better identify and understand the needs of Southern Arizona's unique population. Meaningful collaboration looks like data sharing, thought partnership, and leveraging resources for maximum impact. The ideal partner has a demonstrated track record of intentional and inclusive community engagement (inclusive of rural and tribal populations) and is interested in partnering with a local health department to enhance the reach of our shared efforts. | Heart attack and stroke risk;Opioid overdoses;Serious obstetric complications (maternal health);Alcohol-related health harms; |
| National Association of Community Health Centers | Julia Skapik | jskapik@nachc.com | pcarneiro@nachc.com | Bethesda, MD | NACHC is the member organization for 1486 independent, nonprofit community health centers that in 2022 served 31 million patients. NACHC is actively engaged in critical primary care and public health areas with significant focus in the four ARPA-H proposed areas of focus. NACHC in 2018 through today has supported multiyear projects including: addressing cardiovascular disease through the Million Hearts project, improving maternal quality and outcomes, addressing challenges in safety and patient experience in patients with a history of polysubstance/opiate abuse and chronic pain, improving adolescent and adult reproductive health services, adult immunizations, COVID-19 and pediatric weight management among others. NACHC seeks to understand and deploy successful applied care models and activities that close care gaps, reduce health disparities and improve the care experience in a patient-centered way. | NACHC is looking for health centers and their partners, nonprofits, data partners, payers and community-based organizations to advance ongoing work in improving health equity and access for underserved communities in every US state and territory. NACHC works with health centers to design, deploy and evaluate novel care models and programs that support the national primary care safety net with a focus on reducing health disparities. Potential partners could help by providing data on or building technology-enabled solutions to share and reuse data on health-related social needs and services, inpatient and specialty care, public health, payment and utilization or patient-generated health data. NACHC also seeks organizations who support health centers through electronic health records, patient outreach and population health tools in a cost-effective way. Finally, NACHC is always interested in partners whose expertise is in dissemination and spread of successful ideas. | Serious obstetric complications (maternal health);Heart attack and stroke risk;Opioid overdoses;Alcohol-related health harms; |
| Community Care Network of Kansas | Alice Weingartner | aweingartner@communitycareks.org | sbachus@communitycareks.org | Topeka, KS | As the designated Primary Care Association for Kansas federally qualified health centers and community based clinics, we are focused on improving the overall delivery system to promote more of a focus on preventive health. Ensuring patients are accessing care in the most appropriate door and all Kansans achieving and maintaining their ideal health. | We would benefit from partners with an organization to assist with facilitation of this initiative. We anticipate this being a statewide effort and have begun to identify potential collaborators. We have access to several data systems and would likely need to work with someone who can assist with data integration, review and story telling. There of course is the need for funding to support efforts. | Serious obstetric complications (maternal health);Heart attack and stroke risk;Opioid overdoses;Alcohol-related health harms; |
| Machine | Arda Kara | ardakara@gmail.com | San Francisco, CA | Machine is a group of software engineers who have built Palantir's civilian product and have left after the company's public offering to work on our calling of helping improve preventative health in the US. Over the last decade we have built the core products that enabled data-integration and model assisted decision-making in areas ranging from energy and mining safety/efficiency, PPE supply chain crisis, national COVID responses (eg US HHS Tiberius, UK NHS, EU health ministries), Operation Warpspeed, CA wildfire response and the US 5G rollout, as well as many others we aren't at privilege to talk about. We often build software at a faster rate than our partners' processes around it and target meaningful impact to real world outcomes for them. | We are accepting 200-word proposals from teams with clinical or public health domain expertise and are looking for help accelerating their use of data and software. In our former lives at Palantir, organizations would only get this group's help for contracts in the 8+ digit range but for the right partner we're willing to help out at risk, with any commercials deferred until after reward payments from the project and commensurate to the value our solutions have contributed to the outcome / your desire to keep them. We will be prioritizing teams with a track record of past impact and proposals with the highest level of ambition. | Serious obstetric complications (maternal health);Heart attack and stroke risk;Alcohol-related health harms;Opioid overdoses; | |
| Electronic Caregiver, Inc. | Mark Francis | mfrancis@ecg-hq.com | Las Cruces, NM | Electronic Caregiver is an innovative digital health technology and services company. We provide an open, scalable platform-as-a-service to providers to manage the health of patients. Heart health, pregnancy, and substance abuse are common conditions for which our platform can be deployed to increase engagement with at-risk patients, educate, track key vitals, and deliver care at a distance. | Our system is designed to provide patient and population level health insights. Our PaaS, coupled with our data infrastructure, enables the collection and analysis of large public and private data sets. We seek teaming partners with whom to integrate solutions, provide deep clinical expertise in target conditions, and to reach end patients. | Heart attack and stroke risk;Serious obstetric complications (maternal health);Opioid overdoses;Alcohol-related health harms; | |
| HealthTech Arkansas | Priya Bargoti | priya@healthtecharkansas.com | jeff@healthtecharkansas.com | Bentonville, Arkansas | HealthTech Arkansas is dedicated to improving heart health in Arkansas through strategic partnerships with the state's ten largest hospitals and health systems. The organization's flagship accelerator program, HeartX, selects five global medical device and software companies annually to collaborate with at least two cardiology practices in the state. The goal is to introduce and pilot innovative technologies that contribute to improved patient outcomes while accelerating the development path for CV-based startups. HeartX has become known as the only program in the country that guarantees hospital pilot projects and clinical studies for early-stage companies. Our primary partner in HeartX is MedAxiom, which is the national membership trade organization for the cardiovascular industry. Wholly owned by the American College of Cardiology, MedAxiom drives a number of initiatives focused on improving heart health in our country, including publications focused on best practices and new innovations available for commercial adoption by their 500+ member cardiology practices. As our partner in the ARPA-H HEROES program, MedAxiom provides a natural mechanism for national deployment of best practices developed in HEROES. | Our organization is actively seeking organizations that will help us develop and execute a comprehensive, multi-faceted, compelling HEROES program in the CVD space. HTA and MedAxiom strengths include provider relationships, a deep bench of medtech/healthtech innovations in the CVD space, and core competencies in structuring and executing pilot projects and clinical trials. We seek supplemental expertise in the areas of community health, data extraction and analysis, and access to solutions that are less tech-focused, such as health coaching, health literacy, nutrition, etc. We also seek strategic partnerships with prospective outcome buyers to reduce ASCVD risk in Arkansas. These investments are vital for the success of our cardiovascular initiatives, ensuring sustainable progress beyond the 3-year ARPA-H award. | Heart attack and stroke risk;Serious obstetric complications (maternal health);Opioid overdoses;Alcohol-related health harms; |
| Orchid Healthcare Solutions | Rochelle Prosser | rochelleprosser@orchidhealthcaresolutions.com | rebecca.hunter@orchidhealthcaresolutions.com | Miami Gardens, Florida | Our mission is to extend cancer survivorship in late-stage cancer diagnoses so common in rural areas. The Orchid Oncological Care Navigation Platform addresses the three barriers to cancer care that affect overall survival: Limited Access to Therapeutics, Poor Patient Education, and Healthcare System Navigation, which disproportionately affects vulnerable populations and communities of color. Our Platform expands access to therapeutics through the Taylor-Prosser Library, offering rural providers and patients more treatment options, geolocation, and referral identification. In addition, the Orchid Oncological Care Navigation Platform features a remote nursing care front-end that utilizes WHO’s quality-of-life metrics for point-of-care insights, and our team of remote nurses help navigate common systemic issues such as financial toxicity. Our oncological software platform can stand alone, accommodate other technologies in our platform, or act as a seamless bolt-on to other technologies. We are a mobile unit, facility, pharma and oncology diagnosis agnostic service. Our project strongly aligns with ARPA-H and Cancer X Moonshot goals to improve overall cancer survivorship by 50% in 25 years or less through providing remote oncology care to rural and urban healthcare desert populations. | We are looking for partners to use the Orchid Oncological Care Navigation Platform as either a stand-alone full remote nursing outreach program, to fit within our Platform, or to use our Oncology Care Navigation as a bolt-on service. In addition to care navigation and oncology survivorship, we can address secondary conditions with remote specialty access, patient care-in-place models, and preventative screening to improve the rate of return to initial screening providers. We are focused on ARPA-H HEROS Program seek conversations with potential collaborators to improve rural and urban healthcare services. Website: www.orchidhealthcaresolutions.com | Serious obstetric complications (maternal health);Heart attack and stroke risk;Alcohol-related health harms;Opioid overdoses; |
| Corventive Health Technologies | Mike Meteer, COO | mike.meteer@corventive.com | Boston, MA | Corventive is on a mission to end preventable heart attacks. 50% of heart attacks are the first sign of cardiovascular disease. With our advanced analytic platform we can be your partner for early cardiovascular disease detection before it is too late. Our algorithm reads existing medical records to find often overlooked precursors to heart disease, identifies at-risk patients, and provides relevant and accredited clinical guidance. Appropriate interventions can then be put in place, such as statin medications, catheter procedures, and longer term behavioral modifications, all of which have a direct impact on heart attack risk reduction. Our solution can be implemented quickly and is scalable across large populations to find and target high-risk patients upon an early diagnosis for the greatest health impact. | We are seeking to partner with one or two Accelerators nationally, particularly health systems, with a targeted focus on heart disease risk reduction, and Outcome Buyers with a broader interest in cardiovascular disease detection and treatment. | Heart attack and stroke risk;Alcohol-related health harms;Opioid overdoses;Serious obstetric complications (maternal health); | |
| OnKai, Inc. | Catherine Oidtman | catie@onkai.co | Boca Raton, Florida | OnKai develops innovative AI-based technology to enhance healthcare for underserved communities, ensuring equitable, quality care access for all. OnKai aims to close healthcare gaps for the quarter of the US population that is underserved by combining technology with dynamic business models, symbiotically leveraging nonprofit and for-profit resources to maximize their combined impact. OnKai’s AI-powered SmartGrid, establishes previously unseen connections between diverse stakeholders and generates ready-to-apply solutions, empowering clinics to serve their local communities better. OnKai’s strategy combines community trust, collaboration, and advanced technology to close the gap between care and research that underpins health disparities, with safety-net clinics and their healthcare professionals serving as trusted gateways to their local communities. We are developing a Care and Research Infrastructure in collaboration with leading experts and institutions, designed to empower clinics to elevate quality of care and link underserved populations with specialist centers. This supports safety-net clinics in adopting advanced treatment options, diagnostic tools, and preventative measures, thereby making vital services accessible to communities in need and advancing equitable care outcomes for everyone. The infrastructure facilitates tracking and evaluation of services, population-level research, and more, all aimed at optimizing outcomes and amplifying impact at-scale. | OnKai seeks to collaborate with diverse stakeholders who share our commitment to achieving tangible healthcare improvements for underserved populations. We invite all types of stakeholders such as foundations, investors, buyers, and others to join us in empowering healthcare clinics and professionals treating populations that are underserved with effective and innovative solutions, driving high-quality care and equitable health outcomes for all communities. Let’s build a future where everyone has equitable access to health and well-being. | Heart attack and stroke risk;Serious obstetric complications (maternal health);Opioid overdoses;Alcohol-related health harms; | |
| Medical Society of New Jersey | Lawrence Downs | Ldowns@msnj.org | Shoisington@msnj.org | Lawrenceville, New Jersey | Our core research area is health policy research. | 1. To be feasible, MSNJ would need partners to cover short term funding for capacity building in the organization. 2. To be successful we would need NJ based outcome buyers such as our state employee benefits fund, large employers who are in self funded arrangements. These two types of partners are important because our organization works with private medical practices that struggle to get care delivered (e.g prior authorization barriers) and battle for diminishing payments (claim denials). With the identification of outcome buyers many of the complications of delivering care in a fee for service model go away leaving private practices the ability to innovate. | Serious obstetric complications (maternal health);Opioid overdoses;Heart attack and stroke risk;Alcohol-related health harms; |
| Prealize Health | Wei Wei | wwei@prealizehealth.com | DTolla@prealizehealth.com | San Mateo, CA | Founded by two Stanford University professors with a long history of endeavoring to improve the healthcare system with AI, Prealize Health leverages the latest research from their healthcare AI lab. Our foundation model trained specifically on the intricate language of healthcare data. By processing diverse healthcare data sequences encompassing claims, electronic health records (EHR), Current Procedural Terminology (CPT) codes, International Classification of Diseases (ICD) codes, pharmacy records, laboratory results, and more. We create a longitudinal record of individual’s entire healthcare history and offers unparalleled precision in predicting beneficiary-level health events, including WHEN they will occur, as well as the preferred methods of engagement. Additionally, we leverage social determinants of health data to enhance care management programs, tailoring support to individual needs. Reimagining medicine involves a shift towards predicting, preventing, and precisely treating diseases. Prealize effectively marries two seemingly different approaches: high-tech and high-touch. This transformation tailors healthcare to the unique life circumstances of each individual, enabling the delivery of more proactive and personalized care. By embracing this approach, healthcare providers empower people to take control of their health and lead healthier lives. | We are actively seeking strategic partners who can harness our predictive insights to revolutionize healthcare outcomes, particularly in reducing the risk of Heart Attacks and Strokes, and/or Opioid Overdose within underserved communities. Our mission is to collaborate with organizations throughout the healthcare ecosystem, including payors, providers, integrated delivery systems, value-based care entities, and care management providers. By forging alliances with forward-thinking partners, our aim is to collectively harness the power of our advanced predictive analytics to identify individuals at high risk of these conditions and intervene early to significantly mitigate their risk. Through this collaborative effort, we seek to address healthcare disparities and elevate the quality of care for those most in need. Together, we have the potential to enact meaningful change and empower underserved populations to lead healthier and more fulfilling lives. | Heart attack and stroke risk;Opioid overdoses;Serious obstetric complications (maternal health);Alcohol-related health harms; |
| Imago Rehab | Chris Dugan | Chris.Dugan@ImagoRehab.com | Gene@ImagoRehab.com | Lowell Massachusetts. We operate across multiple states. | Imago Rehab specializes in innovation for stroke and cardiovascular rehab. Novel Clinical Protocol for tele-rehab and soft robotics device technologies deliver 5x clinical outcomes on Fugl Meyer than traditional facility rehab. | We are looking to bring our clinical model in support of this initiative. Imago Rehab wants to support patient populations that have stroke and cardiovascular clinical needs. | Heart attack and stroke risk;Opioid overdoses;Serious obstetric complications (maternal health);Alcohol-related health harms; |
| Arammu | Matt Rubin | matt@arammu.com | James@arammu.com | Worcester, MA | We have done extensive research on proactive, preventative couples checkups, preventative family resilience checkups, and perinatal checkups. We want to expand beyond relational checkups and into more individualized checkup interventions. | We're looking for payers and providers who are forward thinking and see the value of preventative behavioral health to help us further understand and fit the private market. We've spent years perfecting our platform with the Dept. of Defense and are looking to partner and expand in the private sector. | Serious obstetric complications (maternal health);Opioid overdoses;Alcohol-related health harms;Heart attack and stroke risk; |
| SRI International | Hannah Mazur | hannah.mazur@sri.com | Ajay.Divakaran@sri.com | Menlo Park, CA | AI technology—and the creation of new AI technology—are core to the research across SRI. We collaborate to build systems that sense, model, and learn to create ever more capable applications. Our approach is human-centered, emphasizing system transparency and explainability to address the critical issues of predictability and reliability of AI-based systems. We have developed a hierarchical transformer-based method for Causality-aware (CAA) time series analysis. Multi-resolution time series analysis based on causal models is more robust to noisy, corrupted or adversely manipulated data. This enables a ranked identification of specific factors via the underlying causal paths. By focusing on highest ranked factors (preventative measures most likely to be effective in a given region), outcome improvement can be maximized with the least resources. Our causal modeling incorporating time series analysis strives to deliver better health and maximize return on investment. | Health care accelerators and outcome buyers with access to data that can be used for causal modeling and time series analysis to optimize deployment of preventative measures to improve health outcomes across a fixed geography. | Opioid overdoses;Serious obstetric complications (maternal health);Heart attack and stroke risk;Alcohol-related health harms; |
| Atman Health | Calum MacRae | calum@atmanhealth.com | rahulp@atmanhealth.com | Needham, MA | We deliver (via tech-enabled services or SaaS) remote disease management across most of internal medicine, upskilling all levels of clinician to address complex outpatient medical problems at the level of a specialist in the relevant domains. Our platform integrates with EMRs, devices, patient preferences and existing clinical or ancillary teams to enable uniform scalable and cost-effective comprehensive disease management at the point of access. We have deployed in multiple states with multiple partners (payers, providers, communities) in a range of value-based care settings to serve tens of thousands of patients. We have implemented reinforcement learning to enable efficient optimization of our programs in different venues and have deployed in-line A/B testing and formal randomization to allow rigorous testing for elements of care at equipoise. | We are looking to team with outcome buyers in any setting to radically change the efficacy and cost of complex care. | Heart attack and stroke risk;Serious obstetric complications (maternal health);Opioid overdoses;Alcohol-related health harms; |
| Samaritan | Rebecca Stachnik | rebecca@samaritan.city | ap@samaritan.city | Seattle, WA (remote-US) | Samaritan is an engagement platform that empowers unhoused/housing-insecure individuals to address immediate needs and take action steps toward stable housing. Care teams utilize Samaritan to assist clients in overcoming financial and social barriers in order to help address overall health concerns, including chronic conditions associated with homelessness such as substance abuse, maternal health, and cardiovascular disease. Our provision of direct financial and social support facilitates positive behavioral changes, and accelerates progress toward housing, income, and health goals. When immediate needs are met, individuals gain the capacity to remain engaged with the healthcare system, reducing their reliance on emergency care. With over 2,000 Samaritan Members engaged to date, our vision is to assist over 100,000 individuals by 2031. In partnership with healthcare providers, medicaid plans, and community-based organizations, we deploy scalable, data-driven interventions to deliver whole-person support, ensuring a tailored and effective approach to identifying and addressing social determinants of health. Samaritan enables partners to longitudinally track the SDOH progress of their unstably-housed members, enhancing engagement, adherence to care plans, and access to essential services, thereby improving overall health outcomes and reducing healthcare costs for all stakeholders. | We seek partnerships with healthcare providers, medicaid plans, investors, care-based organizations, and government entities dedicated to swiftly enhancing health and housing outcomes for vulnerable and unstably housed populations. Understanding the critical link between social factors and health, we aim to partner in and deploy pragmatic solutions that address root causes, increase engagement, enhance access to essential services, and drive down healthcare expenditures. | Opioid overdoses;Alcohol-related health harms;Serious obstetric complications (maternal health);Heart attack and stroke risk; |
| Prealize Health | Wei Wei | wwei@prealizehealth.com | DTolla@prealizehealth.com | San Mateo, CA | Founded by two Stanford University professors with a long history of endeavoring to improve the healthcare system with AI, Prealize Health leverages the latest research from their healthcare AI lab. Our foundation model trained specifically on the intricate language of healthcare data. By processing diverse healthcare data sequences encompassing claims, electronic health records (EHR), Current Procedural Terminology (CPT) codes, International Classification of Diseases (ICD) codes, pharmacy records, laboratory results, and more. We create a longitudinal record of individual’s entire healthcare history and offers unparalleled precision in predicting beneficiary-level health events, including WHEN they will occur, as well as the preferred methods of engagement. Additionally, we leverage social determinants of health data to enhance care management programs, tailoring support to individual needs. Reimagining medicine involves a shift towards predicting, preventing, and precisely treating diseases. Prealize effectively marries two seemingly different approaches: high-tech and high-touch. This transformation tailors healthcare to the unique life circumstances of each individual, enabling the delivery of more proactive and personalized care. By embracing this approach, healthcare providers empower people to take control of their health and lead healthier lives. | We are actively seeking strategic partners who can harness our predictive insights to revolutionize healthcare outcomes, particularly in reducing the risk of Heart Attacks and Strokes, and/or Opioid Overdose within underserved communities. Our mission is to collaborate with organizations throughout the healthcare ecosystem, including payors, providers, integrated delivery systems, value-based care entities, and care management providers. By forging alliances with forward-thinking partners, our aim is to collectively harness the power of our advanced predictive analytics to identify individuals at high risk of these conditions and intervene early to significantly mitigate their risk. Through this collaborative effort, we seek to address healthcare disparities and elevate the quality of care for those most in need. Together, we have the potential to enact meaningful change and empower underserved populations to lead healthier and more fulfilling lives. | Heart attack and stroke risk;Opioid overdoses;Alcohol-related health harms;Serious obstetric complications (maternal health); |
| Metis Health Technologies | Kim Lynch | kim@metis.health | kimberlyllynch@gmail.com | Chevy Chase, MD | Metis is dedicated to advancing healthcare alignment for better outcomes, starting with foundational measurement. We focus on: 1. Measurement Standardization: We explore how standardizing healthcare measurement around the Quintuple Aim can accelerate innovation diffusion and improve ROI across and within each aim. This includes defining population-level metrics to align business, research, clinician, and patient interests as well as enabling normalized measures like per capita outcomes and costs. 2. Engagement and Alignment: We engage and align buyers and clinicians in service of improved outcomes. Improved visibility into measures leads to more rational decision-making, improved economics, and increased access to care by fostering more resilient provider organizations. 3. Healthcare Innovation: We examine the impact of measurement standardization on healthcare innovation diffusion and specifically outcome based payment models. Standardization can accelerate innovation, growth, and aligned outcomes by fostering clarity and clear communication between business partners. While maternal and fetal outcomes are our top priority for the HEROES program, we are eager to apply our methods across the continuum of care to advance innovation diffusion, repeatability, scalability, and total cost of care alignment. We will transform healthcare by improving clinician economics, leading to greater access, lower prices, and more of the superior outcomes achieved by independent clinicians. | We are in active discussion with several university partners, joining our existing small to medium-sized independent primary care and employer customers. We plan to deliver a business basics curriculum for medical trainees which will support clinical entrepreneurship by giving new physicians the skills needed to operate a small business. Specifically, we are interested in partnering with organizations that have experience or commitment to impacting maternal and fetal health, as well as a demonstrated interest in working with diverse populations and various healthcare payment models. This includes universities, municipalities, small to medium employers, independent primary care and specialty care delivery organizations, FQHCs, academic medical centers, and hospitals. Employers, in particular, stand to benefit from increased employee engagement and satisfaction through their involvement in initiatives that positively impact community health. Finally, we seek partnership with clinically integrated networks and independent physician groups, to prove our hypothesis that improved measurement will lead to better clinician economics, improved patient access, and improved outcomes. We believe that by joining forces with partners who share our vision for improving outcomes and reducing disparities in healthcare, we can accelerate progress and make a meaningful impact on the industry. | Serious obstetric complications (maternal health);Heart attack and stroke risk;Opioid overdoses;Alcohol-related health harms; |
| QT Medical | Ruey-Kang Chang | rk.chang@qtmedical.com | s.wang@qtmedical.com | Diamond Bar, California | QT Medical is a medtech company focusing on electrocardiogram (ECG) technology. Its first product, PCA 500, is the only medical standard 12-lead ECG cleared by the FDA for professional and laypeople use. PCA 500 is compact, digital, wireless, mobile and managed in the cloud. Since its FDA clearance in 2018, PCA 500 has been used on commercial flights, schools, telemedicine, clinical trials, clinics, nursing homes and hospitals. Designed to be user-friendly that can be used by patients with no training or experience, PCA 500 has been sent to thousands of patients to complete their ECG at home with over a 98% success rate. | We are looking for partners who are inetrested in Heart Attack and Stroke Risk as the target outcomes. ECG is the non-inasive, low cost and widely available, and is the most used test for cardiovascular disease prevention, diagnosis and monitoring. PCA 500 can be instrumental in the program design for CV prevention and outcomes improvement. We are seeking partners to use PCA 500 in healthcare facilities, remote sites, rural health, home visits and patient monitoring. PCA 500 offers medical standard 12-lead ECG for use by patients at home with minimal or no training, thus is ideal as the ECG solution for Hospital-At Home programs. | Heart attack and stroke risk;Opioid overdoses;Alcohol-related health harms;Serious obstetric complications (maternal health); |
| Babyscripts | Sarah Nicholson | sarah@babyscripts.com | sophia@babyscripts.com | Washington, DC | Babyscripts’ mission is Better Pregnancies. We are singularly focused on improving maternal health by addressing maternal health risks and contributing factors, both clinical and non-clinical. 80% of maternal deaths are preventable, presenting a significant opportunity to dramatically improve the lives of a large portion of the population; specifically minority women, whose deaths comprise a disproportionate percentage of these rates. | Babyscripts' technology is an extension of the care providers. We are looking to partner with care providers (OBGYNs, Health Systems, Health Plans, Community Based Organizations) to implement our tools to support birthing people during pregnancy and postpartum. | Serious obstetric complications (maternal health);Opioid overdoses;Heart attack and stroke risk;Alcohol-related health harms; |
| CareMessage | Tracy Angelocci, MD | tangelocci@caremessage.org | ccorral@caremessage.org | San Francisco, California (national; completely remote/distributed) | CareMessage is the largest patient activation platform for underserved populations in the United States. A 501(c)3 non-profit with a core focus on health centers and free clinics, CareMessage allows providers to communicate with patients at scale. CareMessage products prompt patients to action, creating more equitable health outcomes. The robust CareMessage platform enables organizations to use mobile messaging to fill gaps in care, provide education, gather patient satisfaction data, remind patients of upcoming appointments, automate follow up for open referrals, and provide one-to-one communication. Nationally, CareMessage is proud to work with over 400 customers in 43 states, comprising 194 FQHCs, free and charitable clinics, and health plans and systems. Using CareMessage, safety-net organizations have reached over 10 million underserved patients with over 300 million text messages since 2013. CareMessage is unique in the market in having published research on improvements in clinical outcomes (conducted by independent academic medical centers). Currently, we are studying the engagement and response patterns among various patient demographic groups. We are also assessing the impact of our text communication services on improving access to care, enhancing clinical outcomes, and connecting patients with resources related to social drivers of health. | The CareMessage platform can fill a pivotal role within a comprehensive cardiovascular health strategy. Our messaging facilitates the management of chronic conditions via appointment recalls and delivers evidence-based health education and self-management programs tailored for chronic conditions, including diabetes and hypertension. Additionally, we offer supplementary programs for tobacco cessation, nutrition, goal setting, and stress management. While we recognize the importance of messaging and patient engagement, we acknowledge that effective clinical interventions must be driven at the health center and provider level. We have fostered partnerships that could potentially align with this initiative, with organizations including population health management vendors, state Primary Care Associations (PCAs), and Health Center Controlled Networks (HCCNs) that are establishing Clinically Integrated Networks for federally qualified health centers. We believe that a larger consortium, perhaps spearheaded by an HCCN, representing many healthcare entities throughout a state and especially with established payer relationships, could serve as a viable avenue for collaboration. | Heart attack and stroke risk;Serious obstetric complications (maternal health);Alcohol-related health harms;Opioid overdoses; |
| Oratel Diagnostics llc | Dorothee Goldman | dorothee@orateldiagnostics.com | dfegoldman@icloud.com | Hammondsport, New York | Oratel Diagnostics is using flavonoids to test components in saliva that are sensitive to hormonal changes. We use spectral data and digital data and have a simple method to collect saliva on a swab that can be dried , shipped to a lab, and evaluated spectrally and histologically to detect certain conditions that affect pelvic pain. | we are looking for potential clinics to use our system as a diagnostic tool. We want to learn both from patients and care givers how our system might be useful. We also want to partner with a medical team and work with a group that knows how to treat patients with pelvic pain. | Alcohol-related health harms;Opioid overdoses;Serious obstetric complications (maternal health);Heart attack and stroke risk; |
| 4BH - ForBetterHealth | Steward Johnson | steward.johnson@4bh.health | peter.lowes@4bh.health | Nashville, TN | 4BH's current research focus areas are centered on the intersection of AI technology and healthcare to enhance preventive care coordination for individuals at-risk for early disease progression. Our key areas include: 1. AI-Driven Predictive Analytics: Developing advanced algorithms to predict the progression of early-stage diseases, such as hypertension, diabetes, and early chronic kidney disease, to enable timely interventions. 2. Digital Care Coordination Tools: Innovating digital solutions that empower community health workers (CHWs) with real-time data and insights to deliver personalized, whole-person care, focusing on social, physical, and behavioral health. 3. Health Outcomes Maximization: Using deep learning and generative AI to analyze vast datasets, improving the effectiveness of care coordination efforts, and ensuring individuals achieve their full health potential. 4. Healthcare Tech Ecosystem Integration: Exploring seamless integration of 4BH’s solutions with existing healthcare systems, EMRs, and wearables to enhance data exchange and support comprehensive care management. 5. Regulatory Compliance and Cybersecurity in Health Tech: Ensuring our innovations adhere to healthcare regulations and standards, emphasizing patient data privacy and security in all our technological advancements. These focus areas aim to revolutionize preventive healthcare delivery, demonstrating significant cost savings for our customers by preventing disease progression and enhancing the quality of life for members. | Outcome buyers and investors who are committed to supporting underserved populations in the South. | Heart attack and stroke risk;Serious obstetric complications (maternal health);Opioid overdoses;Alcohol-related health harms; |
| Imago Rehab | Kristin Nuckols | kristin@imagorehab.com | chris.dugan@imagorehab.com | Lowell, MA | For too long, rehab has meant traveling to a facility to advance recovery. In addition, applying what clients do in a clinic to daily activities can sometimes prove difficult. At Imago Rehab, we use cutting-edge technology, including gamified therapy, to help those with physical impairments restore function and live their most independent lives. Our clients access to innovative therapy and recovery programs from the comfort of their homes. Through remote therapy sessions, our therapists turn daily activities into practical tools to incorporate rehab into everyday life. Imago Rehab was launched out of Harvard University in 2021 after years of research focused on helping individuals recovering from strokes. Our focus has always been on combining the power of virtual rehab services that can be delivered at home with the advancements and innovations happening in the soft robotics and digital health industries. Since then, we have continued to work in partnership with Harvard University’s School of Engineering and Massachusetts General Hospital to help revolutionize stroke recovery, partially funded by the NSF. Our first 100 patients demonstrate incredible motor and functional recovery outcomes which will lead the rehabilitation field once published. We would love to continue our outcomes research in stroke/CVD populations. | Our team is deep with experience in terms of highly skilled rehabilitation therapy, technology development, and business development. We would appreciate teaming partnerships with provider organizations and venture organizations to explore scaling options and exploration into value based care models. | Heart attack and stroke risk;Serious obstetric complications (maternal health);Opioid overdoses;Alcohol-related health harms; |
| United States of Care | Jen DeYoung | jdeyoung@usofcare.org | knakazawa@usofcare.org | Washington, DC | At United States of Care, we are listening to people’s needs, developing policy solutions, and partnering across sectors to ensure our health care system works for everyone. We envision a health care system that provides people with high-quality, personalized care that meets their unique needs at a price they can afford. In this improved, easy-to-navigate system, people will know they can depend on their health care coverage throughout life’s changes, and get the care they need, when and how they need it. Based on what people across demographics need and want from the system, we have created a one-of-a-kind roadmap of a dozen smart and targeted solutions to the most pressing and urgent challenges people face with the health care system. Included in those 12 solutions is a call for better maternal and newborn care. To support our work in this area specifically, we are deploying a number of strategies to bring different sectors across the health care ecosystem together to improve maternal health outcomes and experiences. | United States of Care drives policy change through community engagement, research, advocacy, and convening diverse stakeholders together for collective action. We are interested in working with teaming partners specifically on the maternal health outcome in the HEROES program. We would like to collaborate with community-based organizations, health centers and systems, health tech, and other public and private sector partners across the United States that share a commitment to health equity and upstream interventions to improve maternal health. | Serious obstetric complications (maternal health);Opioid overdoses;Alcohol-related health harms;Heart attack and stroke risk; |
| Be Well Texas (UT Health San Antonio) | Jennifer Sharpe Potter | potterjs@uthscsa.edu | saraiva@uthscsa.edu | San Antonio, Texas | Be Well Texas provides all of Texas with compassionate and transformational care to people who use substances and those with substance use disorder through innovative research, local networks, and engagement, thereby removing stigma, and supporting recovery for patients, their families, and communities. Our vision is transformational change to address substance use and substance use disorders throughout Texas and the nation. We are a low-barrier and inclusive system of care informed by harm reduction and science. In FY23, we served over 35,000 individuals statewide. Our FY24 operating budget is $52M, with support from federal and state sponsors. Be Well Texas is 1) a clinical research program: to develop cutting edge, first-in-class treatments for SUDs; 2) the Be Well Hybrid Clinic: a comprehensive virtual and in-person clinic and research unit that provides compassionate, low-barrier, evidence-based substance use treatment including medications throughout Texas and wrap around services including peer recovery support specialists; 3) a Provider Network of over 140 medication and recovery support community providers; and 4) the Center for Substance Use Training and Telementoring for disseminating best-practices and evidence-based treatment for mental health and substance use to enhance the workforce and provide technical assistance via a network of professional development and consultation providers with extensive reach into Texas’s workforce. | We are innovators with established research and care delivery capabilities leveraging technology in one of the largest states in the nation. We welcome partnering opportunities across the continuum including Health Accelerators, Outcome Buyers, and Investors. | Opioid overdoses;Alcohol-related health harms;Serious obstetric complications (maternal health);Heart attack and stroke risk; |
| Truveta | Margaret Wenzlau | margaretw@truveta.com | Seattle, WA | Truveta is a leader in EHR data and analytics, led by a growing health system collective that together provide more than 18% of all daily clinical care in the US. Truveta is trusted by more than 50 leading healthcare and life science customers to improve patient care, accelerate R&D, and inform public policy. Across these leading organizations, Truveta connects data, people, and ideas to pursue a shared mission of saving lives with data. | Truveta is a leader in EHR data and analytics, led by a growing health system collective that together provide more than 18% of all daily clinical care in the US. Truveta is trusted by more than 50 leading healthcare and life science customers to improve patient care, accelerate R&D, and inform public policy. Across these leading organizations, Truveta connects data, people, and ideas to pursue a shared mission of saving lives with data. | Heart attack and stroke risk;Serious obstetric complications (maternal health);Opioid overdoses;Alcohol-related health harms; | |
| YouScript | Kristine Ashcraft | kristine.ashcraft@youscript.com | valerie.baron@youscript.com | Houston, TX | We currently lose a life every 2 minutes in the U.S. to non-optimized medications at an annual cost of over 528 billion, exceeding the cost of the drugs themselves or any major chronic disease. YouScript’s research focuses on validating tools and implementation methodologies to address this public health crisis. We have published extensively on the clinical and financial benefits of population-based programs designed to reduce medication risk and associated adverse outcomes and costs with targeted pharmacogenomics testing and improved clinical decision support that moves beyond binary over-alerting. Multiple peer reviewed studies have shown our technology in combination with pharmacogenomics testing reduces emergency room visits, hospitalizations, readmission rates, and healthcare costs and we would like to validate that our personalized approach to medication optimization can also dramatically reduce heart attack and stroke risk. | We're looking for payers, providers and fellow healthcare accelerators who are interesting in partnering to create a scalable value-based framework to reduce medication risk and the associated mortality and morbidity at the population level. | Heart attack and stroke risk;Opioid overdoses;Serious obstetric complications (maternal health);Alcohol-related health harms; |
| Sleep & Cradle® Solutions | Cynthia Unuigbe, MD | cynthia@sleepandcradle.com | elijah_george@hotmail.com | Miami | Our organization is at the forefront of investigating the multifaceted implications of chronic sleep deprivation on new mothers. Our research endeavors are meticulously designed to uncover the nuanced effects of insufficient sleep on maternal well-being and mood. We aim to conduct a rigorous scientific study to assess these critical factors before and after the intervention provided by our specialized program. This study will utilize standardized assessment tools to quantify maternal well-being and mood states initially and reassess them post-intervention to evaluate any significant improvements. By doing so, we aspire to establish empirical evidence supporting the efficacy of our program in mitigating the adverse effects of chronic sleep deprivation on new mothers. This research not only contributes to the scientific understanding of sleep deprivation's impact but also paves the way for developing targeted interventions to enhance maternal health and quality of life. | Our organization is in search of teaming partners who share our profound commitment to enhancing maternal and child outcomes. Ideal partners are those dedicated to pioneering innovative solutions and interventions to support the health and well-being of mothers and their children. We value collaborators with expertise in maternal and pediatric health, early childhood development, mental health, and sleep science. Partners should possess a strong foundation in research and evidence-based practices, focusing on generating impactful, sustainable improvements in family health dynamics. We seek entities that are not only aligned with our mission but are also driven by a passion for creating positive change through collaborative efforts. These partnerships will play a crucial role in advancing our research, expanding our program's reach, and ultimately contributing to improving maternal and child health outcomes globally. | Serious obstetric complications (maternal health);Heart attack and stroke risk;Opioid overdoses;Alcohol-related health harms; |
| Circle of Service Foundation | Cristianne Frazier | cristi@cosfoundation.org | yared@cosfoundation.org | Chicago, IL | Circle of Service Foundation is a private foundation that makes grants to support great organizations to enhance community, opportunity, and well-being. Our Medical Research program supports organizations that seek to advance scientific and medical research focused on the diagnosis, prevention, treatment, and cure of cancer and other diseases. Additionally, our Community Services program, which encompasses Cook and Lake Counties, Illinois, supports organizations that help individuals achieve stability in their lives and grow to achieve increasing self-reliance and independence. One of the key focus areas of the Community Services program is Health, which seeks to ensure that all residents of historically disinvested communities have access to quality physical and behavioral healthcare. This involves ensuring that public health systems are resilient and capable of meeting Cook and Lake County’s acute and population health needs in a culturally competent way. | We are interested in connecting with Health Accelerators proposing to implement and test interventions ideally in a geography that includes Chicago. We are particularly interested in interventions that target structural issues known to impact health outcomes, such as access to health care, safe housing and adequate food. We are also interested in connecting with other potential Investors and Outcomes Buyers with shared interests. | Heart attack and stroke risk;Serious obstetric complications (maternal health);Opioid overdoses;Alcohol-related health harms; |
| Decision Analytics Lab at Northeastern University | Muhammad Noor E Alam | mnalam@neu.edu | Boston, MA | Leveraging AI and OR to address the opioid addiction epidemic; Personalized OUD Prescription; Design Optimal Policies for Improving Treatment Retention; Optimal Allocation Policies of Overdose Prevention Toolkit; | We are looking for partners who are willing to share their data relevant to treatment; and willing to collaborate to develop decision support tools, and test and implement them. | Opioid overdoses;Heart attack and stroke risk;Serious obstetric complications (maternal health);Alcohol-related health harms; | |
| NYC Department of Health and Mental Hygiene | Simran Chaudhri | schaudhri@health.nyc.gov | MArroyo@fphnyc.org | New York City, New York | we do everything! tbd | as above. | Opioid overdoses;Serious obstetric complications (maternal health);Heart attack and stroke risk;Alcohol-related health harms; |
| Health Tequity LLC | Katherine Kim | katherine@healthtequity.net | management@healthtequity.net | Berkeley, CA | ACTIVATE by Health Tequity is a unique and vendor-agnostic digital health platform for care coordination and remote patient monitoring with demonstrated and published outcomes in underserved communities. Community healthcare and social needs providers use ACTIVATE to collect remote monitoring data from devices of their choice, engage patients/clients, address digital health literacy challenges, and streamline care coordination workflows for cardiovascular, metabolic, and maternal health. Dashboards provide convenient views to identify patients/clients who are progressing well, those who may need additional support from a health coach or care coordinator, and those who might benefit from a virtual or in-person visit. Data from remote monitoring devices such as glucometers, blood pressure monitors, scales, and fitness trackers are transmitted in real-time and made available both in the dashboard and integrated into the electronic health record system. myACTIVATE mobile application, available for both iOS and Android, gives patients the ability to connect all their remote monitoring devices and automatically transmit the measures. Patients can see the data without having to log into multiple websites. Charts and graphs offer visual summaries of measures over time so a patient/client can clearly see their progress and discuss with their healthcare team. | We seek to partner with accelerators and outcomes buyers focused on maternal health and heart attack and stroke risk. Our digital health platform provides the foundational capacity to engage patients/clients, automate longitudinal, real-world data collection, and deliver data to the partnering organizations. With our experience in underserved communities, we know how to help your patients/clients adopt technology and provide the digital health literacy support to assure the best chances for effectiveness throughout your population. | Serious obstetric complications (maternal health);Heart attack and stroke risk;Opioid overdoses;Alcohol-related health harms; |
| Washington Global Health Alliance (WGHA) | Elana Robertson | elana.robertson@wghalliance.org | kayla.jan@wghalliance.org | Seattle, WA | Washington Global Health Alliance hosts the Global Health Innovation XCHANGE, an impartial membership platform with the mission to advance inclusive and equitable global health innovations by cultivating a dynamic diverse community of private and public visionary organizations and innovators. Our strategic partners span a broad spectrum of the global health landscape, including health organizations like the CDC Foundation, academic institutions such as the University of Washington, government agencies like the Washington State Department of Health, research institutes including the Benaroya Research Institute, and healthcare facilities such as Seattle Children's Hospital, private companies, non-profits, and startups. The XCHANGE aims to create an equitable innovation ecosystem where members can collaborate share innovative ideas, engage in our Co-Incubator Program, and collaborate on grant applications. We have submitted applications as the lead organization in partnership with seven different organizations and their respective technologies for the ARPA-H Women's Sprint. In alignment with our commitment to address diverse health challenges through innovation, we have launched a special initiative within our Co-Incubator Program—the Women's Health Cohort. Through this program, we aim to empower entrepreneurs and innovators who are working on breakthrough solutions that can address the unique health needs faced by women. | One of our organization's strengths are that we are a global organization with access to innovators across the world. We are looking for lead teaming partners, who needs access to innovations in health technology, Digital Health, Health Care System Strengthening and Capacity Building. | Serious obstetric complications (maternal health);Heart attack and stroke risk;Opioid overdoses;Alcohol-related health harms; |
| San Diego Wellness Collaborative | Kitty Bailey | kitty@sdwellnesscollaborative.org | madison@sdwellnesscollaborative.org | San Diego, CA | Our project, Be There San Diego is a multi-sector partnership of community and clinical partners working together to prevent heart attacks and strokes. | We are looking for outcome buyers, other clinical and community organizations, and research partners. | Heart attack and stroke risk;Serious obstetric complications (maternal health);Opioid overdoses;Alcohol-related health harms; |
| Glendor Inc | Julia Komissarchik | julia@glendor.com | Draper UT | We at Glendor are on a quest to safeguard patients’ privacy by de-identifying Protected Health Information (PHI) automatically and at source. Glendor PHI Sanitizer - automatic in situ PHI De-identification software to protect patient’s privacy while empowering BAA-free data sharing and data monetization. Fully Automatic (unlike templates-based solutions that require customization and tweaking) At Source (unlike APIs and 3rd party services that require sensitive data to be shared) Easy to Integrate and Use (no BAA required, 1 min to install and run) Multiple Modalities Multiple Formats Medical Images (Pixels and Metadata) PDFs and Documents Videos and Photographs Voice Recordings and other Medical Data | We are looking for customers and partners who need to cleanse Protected Health Information (PHI) from their data Use Cases Medical Data Sharing Medical Data Monetization RWD/RWE Collection Modalities X-ray, Ultrasound, MRI, CT, PET, OCT, E2E, … Reports, Secondary Capture, … OR Videos, Dermatology Photos, Colonoscopy, … Dictations, Patient Interviews Recordings, … | Heart attack and stroke risk;Serious obstetric complications (maternal health);Alcohol-related health harms;Opioid overdoses; | |
| KAMIN CONSULTING, INC. dba YUMLISH | SHIREEN ABDULLAH | SHIREEN@YUMLISH.COM | GRANTS@YUMLISH.COM | DALLAS, TX | Our organization, Yumlish, is dedicated to pioneering research that examines the impact of culturally affirming nutrition programs on cardiovascular health outcomes, particularly in underserved communities. Our primary focus lies in assessing the effectiveness of our Diabetes Prevention Program (DPP), in reducing the risk factors associated with cardiovascular disease (CVD), such as obesity and diabetes. Our research endeavors encompass rigorous evaluation methodologies to measure the success of our interventions in improving key indicators of cardiovascular health, including weight loss, reduction in A1c levels, and improvements in blood pressure and lipid profiles. We aim to contribute to the growing body of evidence supporting the efficacy of DPPs in preventing not only diabetes but also CVD. Furthermore, our research extends to understanding the unique needs and preferences of diverse populations, ensuring that our programs resonate deeply with the communities we serve. Through partnerships with academia, payers, providers, and outcome buyers, we seek to implement and evaluate our programs, with a focus on scalability and sustainability. Ultimately, our research agenda is driven by a commitment to advancing health equity and reducing the burden of cardiovascular disease among those most affected by disparities in healthcare access and outcomes. | Outcome buyers and investors who are committed to supporting underserved, diverse populations. | Heart attack and stroke risk;Serious obstetric complications (maternal health);Alcohol-related health harms;Opioid overdoses; |
| CHC: Creating Healthier Communities | Nick VanDemark | nvandemark@chcimpact.org | vrochester@chcimpact.org | Alexandria, Va. & Atlanta, Ga. | CHC's maternal health work offers non-clinical support addressing racism, stress and social determinants of health to birthing people in an effort to reduce pre-term birth and improve maternal health outcomes. The BBI emphasizes comprehensive needs assessments and community-led partnerships to address the maternal health crisis through addressing SDoH barriors. It also focuses on providing resources and support to increase availability of doula and other birth advocates. CHC is interested in expanding the impact and research of this work. Ultimately, we are focused on improving standards of care in this space. | CHC is looking for outcome buyers, up-front investors, and community organizations interested in joining to create change in the maternal health space in Atlanta and the surrounding regions. | Serious obstetric complications (maternal health);Heart attack and stroke risk;Opioid overdoses;Alcohol-related health harms; |
| Octagos Health | Twisham Saha | twisham.saha@octagoshealth.com | shanti@octagoshealth.com | Houston, TX | Octagos Health is a cloud-based platform that aggregates remote and in-person interrogation data for implanted cardiac devices, wearables, and remote physiologic monitors. We leverage bidirectional EHR integration with industry leading Atlas AI supported by IBHRE certified technicians to provide timely and accurate reports to clinicians. We have developed a multifaceted approach to remote cardiac event monitoring with a solution that balances the power of cutting-edge software and a human touch with service provided by cardiac device experts. Our solution allows clinicians to focus on other ways of delivering meaningful healthcare and more efficiently manage their remotely monitored patients. It is very useful for the early detection and quantification of atrial fibrillation, prevent hospitalization. | Looking to partner with lead health accelerators. | Heart attack and stroke risk;Serious obstetric complications (maternal health);Opioid overdoses;Alcohol-related health harms; |
| Mission Mobile Medical Group | Travis A. LeFever | tlefever@missionmobilemed.com | mferraris@missionmobilemed.com | Greensboro, NC | We are an innovator who can make a difference here. Our mission is to support the 100m Americans who struggle with access to healthcare, and we're currently doing this work. | We want to partner with health systems and/or providers in rural areas who need a way to execute their care plan across a diverse and distributed geography. We operate in risk-share arrangements, and we're happy to lead the pursuit. | Opioid overdoses;Heart attack and stroke risk;Serious obstetric complications (maternal health);Alcohol-related health harms; |
| HSR.health | Ajay K Gupta | agupta@HSR.health | impact@HSR.health | Rockville, MD | HSR.health is an innovation-first health tech firm, spearheading the utilization of geospatial data and artificial intelligence for healthcare. Supporting public health, emergency response, provider communities, government, industry as well as all organizations impacted by health crises, HSR.health’s proprietary and patented risk data, indicators, and indices enable clients to anticipate health risks to their operations, assets, and the populations they serve. Our solutions served health systems, governmental agencies, and global public health organizations in resource allocation, response planning, as well as gain insights into the factors underlying the human-to-human spread of a viral contagion, as well as the broader market impacts stemming from transmissions. With a team of talented clinicians, public health analysts, data scientists, geospatial engineers, biostatisticians, epidemiologists, and cybersecurity experts, HSR.health is dedicated to remaining on the forefront of healthcare technology innovation – pushing the boundaries of what is possible to anticipate. We believe today’s health crisis demand technological innovation, incorporation of health, social, environmental, and authoritative datasets, deep-insight geospatial mapping and visualization, advanced ML/AI techniques, novel public health models, as well as strategic partnerships that span the industry to provide insights into the health needs of communities, global to local, including those who are most vulnerable. | As an organization dedicated to advancing the capacity of global public health through innovative technologies with the power to predict future health risks before they occur – we seek collaboration with like-minded healthcare accelerators, funders, and outcomes investors interested in deploying these technologies to improve public health outcomes across the opioid epidemic and maternal and child health risks – and especially for the most vulnerable. | Opioid overdoses;Serious obstetric complications (maternal health);Heart attack and stroke risk;Alcohol-related health harms; |
| UMass M2D2 | Alexei Teague | alexei_teague@uml.edu | maryann_picard@uml.edu | Lowell, MA | UMass M2D2 is a medtech/biotech startup incubator and accelerator that is a collaboration between UMass Lowell and UMass Chan Medical School. We provide a host of different business development services that are needed to advance startup companies, from regulatory guidance, help with IP, connections with venture capitalists, to tax guidance. These are just a few of the services our program offers, in addition to physical lab space on both the UMass Lowell and UMass Chan Medical School campuses. In addition, using the resources of both UMass Lowell and UMass Chan Medical School, M2D2 has access to world class researchers and students who are eager to be involved in the innovation community. | We are looking for potential partners who need the resources of a research academic institution (UMass Lowell), a medical school (UMass Chan Medical School), and a medtech/biotech incubator and accelerator (UMass M2D2). Our three combined organizations are looking for entrepreneurs who have a technology that addresses the ARPA-H area of interest, but need partners who can support both their company with business development (reimbursement, IP, regulatory, etc.) and their innovation (research collaboration with professors and students). | Heart attack and stroke risk;Serious obstetric complications (maternal health);Opioid overdoses;Alcohol-related health harms; |
| Havas Lynx | Tania Kotsokechagia | tania.kotsokechagia@havas.com | New York, NY | We are always working with healthcare professionals and global pharmaceutical companies to deliver groundbreaking educational and promotional campaigns to a range of audiences. We cover all therapy areas, including cardiovascular health, women's health, and CNS, including severe pain and opioid dependency. Using creative storytelling we engage audiences and make health information more relatable. By crafting narratives that resonate with people’s experiences, our campaigns effectively convey important messages. Eye-catching visuals, infographics, and videos can simplify complex health information, while gamifying health education can encourage participation and behavior change. Our experience in creating public health campaigns and maximizing social media use, allows us to inspire positive behavior change and achieve desired outcomes. | We would love to team with any organization that is looking to connect with its target audience in meaningful creative ways, while maintaining a foundation of robust scientific knowledge. | Opioid overdoses;Serious obstetric complications (maternal health);Heart attack and stroke risk;Alcohol-related health harms; | |
| Sleep & Cradle® Solutions | Cynthia Unuigbe, MD. | cynthia@sleepandcradle.com | elijah@sleepandcradle.com | Miami | Sleep & Cradle® Solutions is dedicated to improving the quality of life for new parents by addressing the severe impacts of chronic sleep deprivation through comprehensive support and rigorous monitoring. Our tele-health and in-home services focus on enhancing maternal health, especially among underserved communities, by helping parents manage and reduce the incidence chronic sleep deprivation, a risk factor for postpartum depression and related complications. By providing ongoing support for the first year, we aim to mitigate various postnatal challenges effectively. Our research efforts are tailored to assess and quantify the effects of sleep deprivation on maternal well-being and mood both before and after our intervention. We use standardized assessment tools to measure these factors initially and reevaluate them post-intervention to document any significant improvements. This approach not only helps us in refining our support programs but also in identifying mothers at risk of complications, ensuring they receive timely referrals to appropriate medical services. By comparing outcomes with those who did not receive our intervention, we seek to establish empirical evidence of our program's efficacy in reducing the adverse effects of insufficient sleep on new mothers. This research is crucial for advancing the scientific understanding of postnatal sleep deprivation's impact and for developing targeted interventions that substantially enhance maternal health and overall quality of life. | Sleep & Cradle® Solutions is committed to enhancing prenatal and postnatal care. We aim to collaborate with care providers, including health systems, OBGYNs, plans, and community-based organizations, to integrate our supportive tools and services. These partnerships will enable us to deliver targeted support to expectant and new parents, significantly improving perinatal outcomes. | Serious obstetric complications (maternal health);Heart attack and stroke risk;Opioid overdoses;Alcohol-related health harms; |
| Rush University Medical Center | David Ansell, MD, MPH | david_ansell@rush.edu | ajaco@westsideunited.org | Chicago, Illinois | Under the umbrella of West Side United, a racial health equity collaborative comprised of 6 hospitals and community partners, incubated by Rush University System for Health, we are launching a Chicago initiative aimed at reducing cardiovascular disease mortality in Chicago, with a focus on hypertension and other CVD risk factors. The initial focus of this effort will likely be on the West Side of the city, 10 neighborhoods with 550,000 residents, in a program called Live Healthy West Side. There are multiple collaborators who have joined this effort including the AMA, AHA, Chicago Med Society, the Chicago Department of Public Health, Cook County Health, Telligen, and multiple healthcare providers including many in the health care ecosystem. While in the early phase of organizing, two large healthcare collaboratives, Wellness West, comprising over 40 community and healthcare partners on Chicago's West Side, and the Southside Healthy Community Organization, comprised of 13 health care organizations and anchored by U Chicago Medicine on Chicago's Southside have expressed interest in participating in what we hope to be a city-wide population health initiative. | Rush's role in this effort is as a co-convener of this of this initiative, with the Rush BMO Institute for Health Equity, with West Side United and others. As an anchor healthcare institution on Chicago's West Side, we are partnered with U Chicago Medicine, located on Chicago's Southside on many research and equity related initiatives in the region and nationally, including CVD. West Side United has five leading health systems including UI Health (with the UI School of Public Health), Cook County Health, Sinai Health System, Lurie Children's Hospital and Ascension, that have expertise in CVD epidemiology, prevention and treatment. We have many community organizational partners as well as co-partners on this effort. We are seeking partners that want to participate in long-term thinking about CVD mortality reduction in Chicago, can provide time, expertise and investment to this important effort to reduce the number one contributor to the racial life expectancy gap in the City of Chicago. | Heart attack and stroke risk;Serious obstetric complications (maternal health);Opioid overdoses;Alcohol-related health harms; |
| MedicaSafe Inc. | Thomas Lau | thomas.lau@medicasafe.com | matt.ervin@medicasafe.com | New York, NY | Annually, opioid overdoses in the U.S. result in 66 million emergency department (ED) visits and 760,000 inpatient admissions, costing hospitals over $95 billion. EDs are critical for identifying opioid use disorder (OUD) patients and initiating treatment. However, the current practice of providing limited medication and referrals to outpatient prescribers after discharge is inadequate, leading to low enrollment in long-term treatment programs and high rates of readmission, perpetuating the cycle of addiction and overdose. Key Innovation: MedicaSafe Treatment Bridge Patients are initiated into treatment with a prescriber and medication in the ED BEFORE discharge. MedicaSafe's patented technologies provide buprenorphine-naloxone via a tech-enhanced system that allows a remote care team to initiate and facilitate continued treatment iteration by reliably tracking compliance. The Treatment Bridge consists of: • Buprenorphine-naloxone sublingual tablets in tamper-evident cartridges • A connected dispensation system for improved risk evaluation and mitigation strategies (REMS) • Logging and reporting of authorized dose access events • A patented process for deducing diversion or misuse by pairing dispensation data with lab results • A network of prescribers using MedicaSafe technologies for telehealth treatment Proof Points: MedicaSafe technologies are currently powering an NIH-funded study titled "Bridging the gap into treatment," where subjects are randomized to MedicaSafe's system versus treatment as usual. Interim data shows the MedicaSafe cohort has successfully reached the targeted treatment milestone 86% of the time versus 46% for the control group. | Hospital Systems / Emergency Departments Outcome Buyers: 1. Health insurance plans 2. Philanthropy 3. Corporate Foundations 4. Government and Opioid Settlement Funds | Opioid overdoses;Alcohol-related health harms;Heart attack and stroke risk;Serious obstetric complications (maternal health); |
| Beheld LLC | Maninder Kahlon | mini@beheldhealth.com | minikahlon@gmail.com | Austin, TX | We are a small woman-owned business that implements a layperson, telephone-based empathetic engagement program, tested through two clinical trials from an academic laboratory. Our results, published in high quality medical research journals, show not only statistically significant, but also clinically-relevant improvements in mental health and glycemic management for low income patients with uncontrolled diabetes (>1% improvement relative to usual care randomized control). Our model is non-medical, but driven by science and clinical expertise, and coordinates with clinical and payer partners to identify the people who would most benefit, and escalation pathways for those that need clinical attention. | Anyone who wants to implement maternal health or cardiovascular support at scale, especially in rural areas, our evidence-backed, telephone-based program could be a solution. We leverage a novel approach to the workforce, allowing us to bypass behavioral health and healthcare workforce constraints. | Heart attack and stroke risk;Serious obstetric complications (maternal health);Alcohol-related health harms;Opioid overdoses; |
| University of Alabama at Birmingham | Chelsea Crawford | chelseacrawford@uabmc.edu | Birmingham, AL | The Department of Obstetrics and Gynecology (OB/GYN) at the University of Alabama at Birmingham (UAB) is renowned for its comprehensive clinical care, cutting-edge research, and robust educational programs. The mission of UAB OB/GYN Center for Research in Women's Health (CRWH) is to conduct research aimed at improving the health and wellbeing of adolescents, all women and their offspring as well as women finished with child-bearing, especially minority and under-served (including those in rural Alabama). The major research themes at CRWH are currently maternal/child health and gynecologic conditions including genitourinary disorders and cancer prevention (reflecting the spectrum of benign conditions in women as they age) and their intersection with infections, cardiovascular disorders, obesity/diabetes, neurodevelopment and global health. The CRWH has built a reputation of excellence in women's health research over the last three decades. Currently, grant funding for research projects managed by the CRWH exceeds $14M annually. | UAB is interested in taking lead as a health accelerator. We are looking for investors and outcome buyers who want to make a significant impact on severe maternal morbidity and mortality in the Deep South. | Serious obstetric complications (maternal health);Heart attack and stroke risk;Opioid overdoses;Alcohol-related health harms; | |
| Accumen Excellence, Inc | Jason Carney | jcarney@accumen.com | mhollo@accumen.com | Phoenix, AZ | The aim of this project is to leverage MyBloodHealth (MBH) anemia management SAAS tool, in collaboration with Memorial Healthcare Systems (MHS) and other community champions, to improve access and services for preventive prenatal care and reduce Severe Obstetric Complications (SOC) related to the adverse impacts of anemia and red blood cell transfusion (RBCT) exposure. This project will target a 20% improvement in the SOC rate for a higher than national average geographic region in the Broward and Miami-Dade communities of south Florida. A 20% SOC reduction will avoid 804 complications and lower the measured rate to 6.08% for maternal health patients in this community. | Accumen is looking for outcome buyers, investors, and care coordination team support. Care coordination support specifically in the areas of using Accumen's MyBloodHealth tool to connect identified at risk patients with both access to oral iron, IV Iron, and prior authorization in Florida. | Serious obstetric complications (maternal health);Heart attack and stroke risk;Alcohol-related health harms;Opioid overdoses; |
| Mendon Group | Madhu Nair | mnair@mendon.co | smenon@mendon.co | New York | Currently, focused on SBIR projects in the healthcare space- digital solutions / transformation. Two projects completed for CDC | Domain/subject matter researchers & experts to help us formulate research plans | Heart attack and stroke risk;Alcohol-related health harms;Opioid overdoses;Serious obstetric complications (maternal health); |
| KBI Data | Shaun Kahler | shaun@kbi-data.com | shaun.kahler@gmail.com | Knoxville, Tennessee | KBI Data is a small, boutique analytics consultancy specializing in data integration solutions from EHR platforms such as Epic and NextGen. We have 10 years of experience working with healthcare providers across community healthcare clinics, surgical practices, and hospitals in the U.S. | We are a small data integration and analytics consultancy looking for partners based in the southeastern United States who are interested in using technology to research and mitigate the rural opioid crisis. | Opioid overdoses;Alcohol-related health harms;Heart attack and stroke risk;Serious obstetric complications (maternal health); |
| Mayo Clinic | Sagar Dugani, MD, PhD, MPH | dugani.chandrasagar@mayo.edu | Rochester, Minnesota | We are developing a proposal to reduce cardiovascular risk in Minnesota, a state with a high burden of cardiovascular risk and with substantial rural-urban health disparities. | We are interested in working with Outcome Buyers, Investors, and companies who are interested in reducing cardiovascular risk. We are interested in working with organizations who have user-friendly technology to increase medication adherence and generate educational content. | Heart attack and stroke risk;Serious obstetric complications (maternal health);Opioid overdoses;Alcohol-related health harms; | |
| Penn State University College of Medicine | Vida Abedi, Associate Professor, Public Health Sciences | vabedi@pennstatehealth.psu.edu | nsellakapu@pennstatehealth.psu.edu | Hershey, Pennsylvania | Our team is well-equipped with clinical and artificial intelligence (AI) expertise, with a primary focus on Ischemic Stroke and related comorbidities and risk factors. We have a dedicated team of Data Scientists and Engineers, complemented by Medical expertise, to help improve the health of patients and patient populations - both at the personalized level and at the population level. We have developed AI-powered outcome prediction models to help improve secondary prevention while optimizing available resources; we have used the electronic health records (EHR) data to identify care gaps to improve the risk of stroke in patients with atrial fibrillation; we have worked extensively to understand better ischemic stroke in younger patients, who may not always benefit from traditional prevention strategies. | We are to open to partner with lead organizations who plan to respond to HEROES and offer our expertise and resources. | Heart attack and stroke risk;Serious obstetric complications (maternal health);Opioid overdoses;Alcohol-related health harms; |